ofloxacin has been researched along with Acute Disease in 152 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The purpose of this study was to determine the intrapulmonary profile of high-dose (750 mg) levofloxacin in patients during an acute exacerbation of chronic bronchitis (AECB)." | 9.16 | Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis. ( Baughman, RP; Nicolau, DP; Sutherland, C; Winget, D, 2012) |
| "A clinical study was conducted to compare the efficacy and safety of levofloxacin 750 mg once daily for 5 days to ciprofloxacin twice daily for 10 days for the treatment of complicated urinary tract infections (cUTI) or acute pyelonephritis (AP)." | 9.13 | A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. ( Fisher, AC; Kahn, JB; Kaul, S; Khashab, M; Peterson, J, 2008) |
| "Compare two dosage strengths of levofloxacin in the treatment of acute bacterial sinusitis." | 9.12 | A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis. ( Anon, J; Kahn, J; Khashab, M; Paglia, M; Poole, M; Xiang, J, 2006) |
| "Levofloxacin has excellent activity against common respiratory pathogens and therefore is likely to be effective in treating children with persistent or recurrent otitis media." | 9.12 | An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media. ( Arguedas, A; Blumer, J; Dagan, R; Leibovitz, E; McNeeley, DF; Melkote, R; Noel, GJ; Pichichero, M, 2006) |
| "This study assessed daily aspirate samples from an indwelling sinus catheter during high-dose, short-course levofloxacin (750 mg daily x 5 days) treatment of acute maxillary sinusitis." | 9.12 | Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis. ( Ambrose, PG; Anon, JB; Jones, RN; Kahn, JB; Paglia, M; Xiang, J, 2007) |
| "A double-blind, noninferiority trial was conducted to establish the safety and efficacy of a once-daily, 5-day course of levofloxacin 750 mg compared to a twice-daily, 10-day course of ciprofloxacin in complicated urinary tract infections (cUTI) and acute pyelonephritis (AP)." | 9.12 | A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis. ( Brown, P; Fisher, AC; Kahn, JB; Kaul, S; Khashab, M; Klausner, HA; Peterson, J, 2007) |
| "This study compared the clinical efficacy and tolerability of cefdinir and levofloxacin in patients with a diagnosis of acute rhinosinusitis of presumed bacterial origin." | 9.11 | Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study. ( Busman, TA; Henry, DC; Kapral, D; Paris, MM, 2004) |
| "The authors had for aim to evaluate the efficacy and tolerance of oral levofloxacin (500 mg once a day during ten days), as a treatment for acute bacterial sinusitis at risk for complications in adult patients." | 9.11 | [Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications]. ( Gehanno, P; Pessey, JJ; Serrano, E, 2005) |
| "The clinical effect of Levofloxacin and Ceftriaxone in patients with acute cholangitis showed no significant differences." | 9.10 | [Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis]. ( Genitsariotis, R; Hahn, M; Jung, M; Kiesslich, R; Mäurer, M; Nafe, B; Will, D, 2003) |
| "A multicentre randomized controlled clinical trial was conducted to compare sparfloxacin versus ofloxacin in the treatment of acute bacterial infections." | 9.10 | [Multicenter evaluation on the efficacy and safety of sparfloxacin in the treatment of acute bacterial infections]. ( Cai, Y; Liang, D; Miao, J; Qiu, D; Wen, C; Xu, N, 2002) |
| "To compare the safety and efficacy of oral azithromycin and levofloxacin in the treatment of outpatients with acute bacterial exacerbations of chronic bronchitis (ABECB)." | 9.10 | Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis. ( Amsden, GW; Baird, IM; Simon, S; Treadway, G, 2003) |
| "In this comparative trial, outpatients with acute sinusitis were randomly assigned to receive levofloxacin (500 mg orally once daily) or amoxicillin-clavulanate (500/125 mg orally 3 times daily) for 10 to 14 days." | 9.09 | Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults. ( Adelglass, J; Campbell, T; DeAbate, CA; Fowler, CL; LoCocco, J; McElvaine, P, 1999) |
| "A prospective randomized study was performed in order to compare the efficacy of oral levofloxacin, a new S- isomer of ofloxacin, with intravenous ceftazidime in the empirical treatment of acute exacerbations of bronchiectasis." | 9.09 | A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis. ( Chan, K; Chan, WM; Ho, PL; Ip, MS; Lam, WK; Tsang, KW, 1999) |
| "To investigate the safety, efficacy and recurrence-inhibiting effect of a single dose of levofloxacin (LVFX) for the treatment of acute uncomplicated cystitis in women, 56 females with acute uncomplicated cystitis between 17 and 73 years old were studied, based on the urinary tract infection (UTI) drug efficacy evaluation." | 9.09 | [Efficacy of single-dose therapy with levofloxacin for acute cystitis: comparison to three-day therapy]. ( Amazutsumi, K; Harada, T; Kawamura, H; Koyama, Y; Matsuda, T; Mikami, O; Murota, T; Ohara, T; Uchida, J, 2000) |
| "Eradication of non-typhoid salmonellae was evaluated in a randomized, double-blinded study of 49 patients with acute enteritis after therapy with ofloxacin 400 mg once daily for 5 or 10 days." | 9.09 | Eradication of non-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or 10 days. ( Digranes, A; Halstensen, A; Langeland, N; Peterson, LE; Rolstad, T; Solberg, CO; Voltersvik, P, 2000) |
| "A randomized, double-blind, multicentre study was conducted in adult patients with acute exacerbation of chronic bronchitis (AECB), to compare the efficacy of a 5-day course of levofloxacin 500 mg once daily, with the standard 7-day regimen at the same dose." | 9.09 | Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis. ( Burley, CJ; Masterton, RG, 2001) |
| "To evaluate the efficacy and safety of levofloxacin (500 mg orally once daily for 10 to 14 days) in treating adult outpatients with acute bacterial sinusitis." | 9.08 | Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults. ( Anthony, KE; Fowler, CL; Kim, SS; Kopp, EJ; LoCoco, JM; Sydnor, TA, 1998) |
| "To evaluate, in two randomized, multicenter trials, levofloxacin compared with ciprofloxacin and lomefloxacin for efficacy and safety in treating acute pyelonephritis." | 9.08 | Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. ( Callery-D'Amico, S; Fowler, CL; Kim, SS; Klimberg, IN; Richard, GA, 1998) |
| "Comparison of efficacy and safety of sparfloxacin vs ofloxacin for treatment of acute bacterial exacerbations of chronic bronchitis (ABECB)." | 9.08 | Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group. ( Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D, 1998) |
| "Adult patients with acute sinusitis (n = 236) were randomized in a double-blind study to levofloxacin 500 mg orally once daily (n = 119) or clarithromycin 500 mg orally twice daily (n = 117) for 10-14 days." | 9.08 | Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. ( Anstey, RJ; Lasko, B; Lau, CY; Martel, A; Reddington, JL; Saint-Pierre, C, 1998) |
| "A comparative study of ofloxacin (OFLX), a new oral quinolone, was carried out at the Department of Urology, Osaka University Hospital and its eighteen affiliated hospitals to evaluate the clinical efficacy and safety of daily dose of 300 mg, given either once daily dose (SID group), or in three divided doses (TID group), in the treatment of acute uncomplicated cystitis in women." | 9.07 | [Clinical evaluation on ofloxacin administered once daily in the treatment of acute uncomplicated cystitis]. ( Fujioka, H; Kishimoto, T; Kokado, Y; Kuroda, H; Miki, T; Oda, M; Okuyama, A; Takatera, H; Yamada, R; Yasunaga, Y, 1994) |
| "We compared the safety and efficacy of a single 400-mg dose of ofloxacin, ofloxacin (200 mg) once daily for 3 days, and trimethoprim-sulfamethoxazole (160:800 mg) twice daily for 7 days for the treatment of acute uncomplicated cystitis (urinary tract infection [UTI]) in women." | 9.07 | Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. ( Hooton, TM; Johnson, C; Kuwamura, L; Roberts, PL; Rogers, ME; Stamm, WE; Winter, C, 1991) |
| "The object of this randomized study was to compare the safety and efficacy of oral ofloxacin, 400 mg twice daily for 10 days, versus intramuscular cefoxitin, 2 gm, plus oral probenecid, 1 gm, followed by oral doxycycline, 100 mg twice daily for 10 days, in the outpatient treatment of uncomplicated acute salpingitis." | 9.07 | A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. ( Bawdon, RE; Cox, SM; Heard, MC; Nobles, BJ; Theriot, SK; Wendel, GD, 1991) |
| "We compared the safety and efficacies of ofloxacin and trimethoprim-sulfamethoxazole for the treatment of acute uncomplicated cystitis in women enrolled in a multicenter study." | 9.06 | Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. ( Hooton, TM; Johnson, C; Latham, RH; Roberts, PL; Stamm, WE; Wong, ES, 1989) |
| "Ofloxacin (OFLX) was administered to 236 female patients with acute cystitis." | 9.06 | [Clinical evaluation of ofloxacin in the treatment of acute cystitis]. ( Koyanagi, T; Kubota, M; Kumagai, A; Maru, A; Nantani, M; Sakakibara, N; Sakashita, S; Togashi, M; Tsubo, S; Yamazaki, H, 1987) |
| "We report a case of lethal hepatitis possibly/probably associated with levofloxacin, doxy-cycline, and naproxen in a patient with acute M pneumoniae infection." | 7.75 | Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. ( Andrade, RJ; Carrascosa, MF; Caviedes, JR; Lavín, AC; Lucena, MI; Mones, JC; Rivero, AP; Serrano, VB, 2009) |
| "The objective of this study was to assess the in vitro activity of levofloxacin compared to other antibiotics against Escherichia coli strains isolated from female patients with acute pyelonephritis in 23 French hospitals in 2005." | 7.74 | [In vitro activity of levofloxacin against Escherichia coli strains in acute pyelonephritis, in France in 2005]. ( Dib-Smahi, C; Lascols, C; Soussy, CJ, 2007) |
| "A previous study found that a single 2-g dose of azithromycin extended release (AZ-ER) was as efficacious as 10 days of levofloxacin (LFX) 500 mg QD in adults with acute bacterial rhinosinusitis (ABRS)." | 7.74 | Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial. ( de Caprariis, PJ; Marple, BF; Reisman, A; Roberts, CS, 2007) |
| "The PharMetrics Patient-Centric claims database was searched over a 3-year period for episodes of acute rhinosinusitis treated within 5 days with moxifloxacin or levofloxacin." | 7.73 | Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges. ( Friedman, HS; Keating, KN; Perfetto, EM, 2006) |
| "The appropriate administration method of levofloxacin in relation to symptoms was investigated by following up 2,353 patients prescribed either levofloxacin (300 mg divided into 3 doses) or 400 mg (divided into 2 doses) for the treatment of acute upper respiratory tract infection accompanied by fever (temperature (> or = 38 degrees C) of suspected bacterial infection." | 7.72 | [Use of the antibacterial agent levofloxacin for acute upper respiratory tract infection accompanied by fever (> or = 38 degrees C)]. ( Matsumoto, T; Odagiri, S; Uchino, K; Yamaguchi, H; Yokoyama, H, 2003) |
| "Studies of acute exacerbations of chronic bronchitis (EXCB) included in the approval documents of levofloxacin (LVF) were reviewed in light of the good conditions of use defined by the French marketing approval and the AFSSAPS recommendations." | 7.72 | [Efficacy of levofloxacin in the treatment of acute exacerbation of chronic bronchitis in patients with risk factors]. ( Brumpt, I; Veyssier, P; Zuck, P, 2004) |
| "THE EFFICACY OF LEVOFLOXACIN: In treating community-acquired pneumonia (CAP) has been assessed during 5 large clinical trials (including 4 controlled randomized trials)." | 7.71 | [Update on the role of levofloxacin in the management of acute community-acquired pneumonia]. ( Bru, JP, 2002) |
| "We investigated the use of an ofloxacin-impregnated bioabsorbable composite for the prevention of acute Staphylococcus aureus osteomyelitis." | 7.70 | Prophylaxis of acute osteomyelitis with absorbable ofloxacin-impregnated beads. ( Kourea, HP; Nicolau, DP; Nie, L; Nightingale, CH; Tessier, PR, 1998) |
| " In a murine model of hematogenous pyelonephritis, the in vivo efficacies of levofloxacin and ciprofloxacin were evaluated against two methicillin-susceptible and two methicillin-resistant S." | 7.69 | In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains. ( Barrett, JF; Frosco, MB; Kulwich, BA; Licata, L; Melton, JL; Stewart, FP, 1996) |
| "We attempted to define the microbiologic characteristics of acute salpingitis in women presenting to an urban emergency department with pelvic inflammatory disease and to determine the effectiveness of ofloxacin in treating this disease." | 7.68 | Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. ( Brockwell, NJ; Dalton, HP; Soper, DE, 1992) |
| "We have compared the efficacy of temafloxacin against Streptococcus pneumoniae in experimental murine pneumonia models with that of ofloxacin and ciprofloxacin." | 7.68 | Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin. ( Azoulay-Dupuis, E; Bedos, JP; Pocidalo, JJ; Vallée, E, 1991) |
| "In a prospective study, 70 men suffering from uncomplicated acute unilateral epididymitis were treated initially with 2 x 200 mg ofloxacin p." | 7.68 | [Initial therapy of acute unilateral epididymitis using ofloxacin. I. Clinical and microbiological findings]. ( Friedrich, HJ; Garbe, C; Harbrecht, J; Kleinschmidt, K; Schiefer, HG; Weidner, W; Weissbach, L, 1990) |
| "The aim of this study was to assess the clinical efficacy of a combination of penicillin G and ofloxacin in the treatment of community acquired pneumonia." | 7.68 | [The combination of penicillin G and ofloxacin: a response to the empirical treatment of community acquired pneumonia]. ( Canton, P; Dopff, C; Dureux, JB; Gerard, A; May, T; Mertes, PM; Nace, L; Preiss, MA; Voiriot, P, 1990) |
| "After ascertaining the bacterial spectrum in 105 patients with Otitis media acutissima, Otitis media chronica mesotympanalis and Otitis media chronica epitympanalis, the efficacy of oral therapy with ofloxacin in five patients from each of these groups was assessed." | 7.67 | [Ofloxacin in the conservative therapy of acute and chronic otitis media--a preliminary clinical report of experiences]. ( Lenarz, T, 1986) |
| "After ascertaining the bacterial spectrum in 210 patients with Otitis media acuta, Otitis media chronica mesotympanalis and Otitis media chronica epitympanalis, the clinical efficacy of oral therapy with ofloxacin in 40 patients from each of these groups was assessed." | 7.67 | Ofloxacin in oral chemotherapy of acute and chronic otitis media. ( Lenarz, T, 1986) |
| "Fifty-three patients with urinary tract infections (UTI) were treated with Ofloxacin, a new oral synthetic antimicrobial agent, and its clinical efficacy was studied." | 7.67 | [Clinical study of ofloxacin (OFLX) on urinary tract infections]. ( Inada, F; Inagaki, N; Miyata, M; Mizunaga, M; Morikawa, M; Okamura, K; Osanai, H; Yachiku, S, 1987) |
| "Levofloxacin reduced the bacterial infections and delays the onset of fever in chemotherapy-induced neutropenia especially in short duration (< 7 days)." | 6.74 | Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia. ( Khan, MA; Rahman, MM, 2009) |
| "Levofloxacin is a fluoroquinolone antimicrobial agent for which pharmacodynamic relationships between the maximum serum antibiotic concentration (Cmax)/minimum inhibitory concentration (MIC) ratio and/or the area under the serum concentration-time curve during a 24-h dosing period (AUC(0-24))/MIC ratio and clinical and/or microbiological outcomes have been developed." | 6.71 | Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis. ( Blasi, F; Cazzola, M; Donnarumma, G; Marchetti, F; Matera, MG; Sanduzzi, A; Tufano, MA, 2005) |
| "Ofloxacin appears to be an appropriate antibiotic for short term therapy of acute, uncomplicated, lower urinary tract infections, comparing favourably with trimethoprim-sulphamethoxazole treatment in this study." | 6.66 | Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. ( Bjertnaes, A; Block, JM; Hafstad, PE; Holte, M; Ottemo, I; Peterson, LE; Rolstad, T; Svarva, PL; Walstad, RA, 1987) |
| "The patient was diagnosed with acute tubulointerstitial nephritis caused by cefdinir." | 5.31 | Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure. ( Fujiwara, T; Hiramori, K; Kawamura, M; Kimura, Y; Maesawa, C; Owada, M, 2001) |
| " The purpose of this study was to determine the intrapulmonary profile of high-dose (750 mg) levofloxacin in patients during an acute exacerbation of chronic bronchitis (AECB)." | 5.16 | Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis. ( Baughman, RP; Nicolau, DP; Sutherland, C; Winget, D, 2012) |
| "To evaluate the clinical and bacterial efficacies and the safety of antofloxacin hydrochloride tablets in the treatment of acute exacerbations of chronic bronchitis (AECB) and acute pyelonephritis (AP)." | 5.14 | A phase II study of antofloxacin hydrochloride, a novel fluoroquinolone, for the treatment of acute bacterial infections. ( Bai, C; Huang, W; Mei, C; Wang, J; Xiao, Y; Xiu, Q; Xu, N; Zheng, Q, 2010) |
| "A clinical study was conducted to compare the efficacy and safety of levofloxacin 750 mg once daily for 5 days to ciprofloxacin twice daily for 10 days for the treatment of complicated urinary tract infections (cUTI) or acute pyelonephritis (AP)." | 5.13 | A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. ( Fisher, AC; Kahn, JB; Kaul, S; Khashab, M; Peterson, J, 2008) |
| "Compare two dosage strengths of levofloxacin in the treatment of acute bacterial sinusitis." | 5.12 | A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis. ( Anon, J; Kahn, J; Khashab, M; Paglia, M; Poole, M; Xiang, J, 2006) |
| "Levofloxacin has excellent activity against common respiratory pathogens and therefore is likely to be effective in treating children with persistent or recurrent otitis media." | 5.12 | An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media. ( Arguedas, A; Blumer, J; Dagan, R; Leibovitz, E; McNeeley, DF; Melkote, R; Noel, GJ; Pichichero, M, 2006) |
| "This study assessed daily aspirate samples from an indwelling sinus catheter during high-dose, short-course levofloxacin (750 mg daily x 5 days) treatment of acute maxillary sinusitis." | 5.12 | Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis. ( Ambrose, PG; Anon, JB; Jones, RN; Kahn, JB; Paglia, M; Xiang, J, 2007) |
| "A double-blind, noninferiority trial was conducted to establish the safety and efficacy of a once-daily, 5-day course of levofloxacin 750 mg compared to a twice-daily, 10-day course of ciprofloxacin in complicated urinary tract infections (cUTI) and acute pyelonephritis (AP)." | 5.12 | A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis. ( Brown, P; Fisher, AC; Kahn, JB; Kaul, S; Khashab, M; Klausner, HA; Peterson, J, 2007) |
| "The objective of the study was to compare the clinical efficacy and bacteriological response of levofloxacin and amoxicillin/clavulanic acid (co-amoxiclav) in the treatment of purulent maxillary sinusitis." | 5.11 | An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients. ( Bunnag, C; Dhiraputra, C; Fooanant, S; Jareoncharsri, P; Srifuengfung, S; Tunsuriyawong, P; Voraprayoon, S, 2004) |
| "This study compared the clinical efficacy and tolerability of cefdinir and levofloxacin in patients with a diagnosis of acute rhinosinusitis of presumed bacterial origin." | 5.11 | Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study. ( Busman, TA; Henry, DC; Kapral, D; Paris, MM, 2004) |
| "The authors had for aim to evaluate the efficacy and tolerance of oral levofloxacin (500 mg once a day during ten days), as a treatment for acute bacterial sinusitis at risk for complications in adult patients." | 5.11 | [Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications]. ( Gehanno, P; Pessey, JJ; Serrano, E, 2005) |
| "0-g dose of a novel azithromycin microsphere formulation with that of 10 days of levofloxacin, 500 mg/d, when used to treat adults with uncomplicated acute bacterial maxillary sinusitis (ABS)." | 5.11 | Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults. ( Breen, JD; Emparanza, P; Lesinskas, E; Murray, JJ; Tawadrous, M, 2005) |
| "The clinical effect of Levofloxacin and Ceftriaxone in patients with acute cholangitis showed no significant differences." | 5.10 | [Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis]. ( Genitsariotis, R; Hahn, M; Jung, M; Kiesslich, R; Mäurer, M; Nafe, B; Will, D, 2003) |
| "A multicentre randomized controlled clinical trial was conducted to compare sparfloxacin versus ofloxacin in the treatment of acute bacterial infections." | 5.10 | [Multicenter evaluation on the efficacy and safety of sparfloxacin in the treatment of acute bacterial infections]. ( Cai, Y; Liang, D; Miao, J; Qiu, D; Wen, C; Xu, N, 2002) |
| "To compare the safety and efficacy of oral azithromycin and levofloxacin in the treatment of outpatients with acute bacterial exacerbations of chronic bronchitis (ABECB)." | 5.10 | Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis. ( Amsden, GW; Baird, IM; Simon, S; Treadway, G, 2003) |
| "In this comparative trial, outpatients with acute sinusitis were randomly assigned to receive levofloxacin (500 mg orally once daily) or amoxicillin-clavulanate (500/125 mg orally 3 times daily) for 10 to 14 days." | 5.09 | Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults. ( Adelglass, J; Campbell, T; DeAbate, CA; Fowler, CL; LoCocco, J; McElvaine, P, 1999) |
| "A prospective randomized study was performed in order to compare the efficacy of oral levofloxacin, a new S- isomer of ofloxacin, with intravenous ceftazidime in the empirical treatment of acute exacerbations of bronchiectasis." | 5.09 | A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis. ( Chan, K; Chan, WM; Ho, PL; Ip, MS; Lam, WK; Tsang, KW, 1999) |
| "To investigate the safety, efficacy and recurrence-inhibiting effect of a single dose of levofloxacin (LVFX) for the treatment of acute uncomplicated cystitis in women, 56 females with acute uncomplicated cystitis between 17 and 73 years old were studied, based on the urinary tract infection (UTI) drug efficacy evaluation." | 5.09 | [Efficacy of single-dose therapy with levofloxacin for acute cystitis: comparison to three-day therapy]. ( Amazutsumi, K; Harada, T; Kawamura, H; Koyama, Y; Matsuda, T; Mikami, O; Murota, T; Ohara, T; Uchida, J, 2000) |
| "Eradication of non-typhoid salmonellae was evaluated in a randomized, double-blinded study of 49 patients with acute enteritis after therapy with ofloxacin 400 mg once daily for 5 or 10 days." | 5.09 | Eradication of non-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or 10 days. ( Digranes, A; Halstensen, A; Langeland, N; Peterson, LE; Rolstad, T; Solberg, CO; Voltersvik, P, 2000) |
| "A randomized, double-blind, multicentre study was conducted in adult patients with acute exacerbation of chronic bronchitis (AECB), to compare the efficacy of a 5-day course of levofloxacin 500 mg once daily, with the standard 7-day regimen at the same dose." | 5.09 | Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis. ( Burley, CJ; Masterton, RG, 2001) |
| "A 3-day regimen of trimethoprim-sulfamethoxazole is more effective and less expensive than 3-day regimens of nitrofurantoin, cefadroxil, or amoxicillin for treatment of uncomplicated cystitis in women." | 5.08 | Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. ( Hooton, TM; Stamm, WE; Tiu, F; Winter, C, 1995) |
| "Fifteen patients with various forms of pyelonephritis and chronic cystitis were treated with ofloxacin." | 5.08 | [Comprehensive treatment with ofloxacin in pyo-inflammatory urologic diseases]. ( Pytel', IuA; Volkova, VS, 1996) |
| "To evaluate the efficacy and safety of levofloxacin (500 mg orally once daily for 10 to 14 days) in treating adult outpatients with acute bacterial sinusitis." | 5.08 | Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults. ( Anthony, KE; Fowler, CL; Kim, SS; Kopp, EJ; LoCoco, JM; Sydnor, TA, 1998) |
| "To evaluate, in two randomized, multicenter trials, levofloxacin compared with ciprofloxacin and lomefloxacin for efficacy and safety in treating acute pyelonephritis." | 5.08 | Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. ( Callery-D'Amico, S; Fowler, CL; Kim, SS; Klimberg, IN; Richard, GA, 1998) |
| "Comparison of efficacy and safety of sparfloxacin vs ofloxacin for treatment of acute bacterial exacerbations of chronic bronchitis (ABECB)." | 5.08 | Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group. ( Bensch, G; Chodosh, S; DeAbate, CA; Harper, L; Henry, D; Jubran, A; Talbot, GH; Tipping, D, 1998) |
| "The efficacy and safety of a 3-day regimen of sparfloxacin were compared with those of a 3-day regimen of ofloxacin for the treatment of community-acquired acute uncomplicated urinary tract infections." | 5.08 | Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group. ( Dorr, MB; Ellison, W; Henry, D; Magner, DJ; Mansfield, DL; Sullivan, J; Talbot, GH, 1998) |
| "Adult patients with acute sinusitis (n = 236) were randomized in a double-blind study to levofloxacin 500 mg orally once daily (n = 119) or clarithromycin 500 mg orally twice daily (n = 117) for 10-14 days." | 5.08 | Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group. ( Anstey, RJ; Lasko, B; Lau, CY; Martel, A; Reddington, JL; Saint-Pierre, C, 1998) |
| "A comparative study of ofloxacin (OFLX), a new oral quinolone, was carried out at the Department of Urology, Osaka University Hospital and its eighteen affiliated hospitals to evaluate the clinical efficacy and safety of daily dose of 300 mg, given either once daily dose (SID group), or in three divided doses (TID group), in the treatment of acute uncomplicated cystitis in women." | 5.07 | [Clinical evaluation on ofloxacin administered once daily in the treatment of acute uncomplicated cystitis]. ( Fujioka, H; Kishimoto, T; Kokado, Y; Kuroda, H; Miki, T; Oda, M; Okuyama, A; Takatera, H; Yamada, R; Yasunaga, Y, 1994) |
| " In a prospective, randomized, open trial, we evaluated the efficacy and safety of oral roxithromycin (150 mg twice daily) as additional antibacterial prophylaxis in 131 adult patients with acute leukemia and bone marrow transplant recipients receiving oral ofloxacin." | 5.07 | A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. ( Arnold, R; Hay, B; Kern, P; Kern, WV; Marre, R, 1994) |
| "A total of 125 ambulatory women (85 premenopausal and 40 postmenopausal) who experienced 174 acute urinary tract infections with mainly gram-negative bacteria (99%) was randomized to receive a single dose, 2-tablet treatment with either ofloxacin (400 mg." | 5.07 | Single dose quinolone treatment in acute uncomplicated urinary tract infection in women. ( Pfau, A; Sacks, TG, 1993) |
| "Two different oral ofloxacin regimens, daily single-dose treatment with 200 mg (Regimen I) and every two week multidose treatment with 3 x 200 mg/day (Regimen II), were compared to evaluate the efficacy of quinolone regimens in controlling acute exacerbations of chronic respiratory tract infections." | 5.07 | Once daily versus every two week multidose ofloxacin in patients with acute exacerbations of chronic respiratory disease. ( Watanabe, A, 1991) |
| "We compared the safety and efficacy of a single 400-mg dose of ofloxacin, ofloxacin (200 mg) once daily for 3 days, and trimethoprim-sulfamethoxazole (160:800 mg) twice daily for 7 days for the treatment of acute uncomplicated cystitis (urinary tract infection [UTI]) in women." | 5.07 | Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women. ( Hooton, TM; Johnson, C; Kuwamura, L; Roberts, PL; Rogers, ME; Stamm, WE; Winter, C, 1991) |
| "The object of this randomized study was to compare the safety and efficacy of oral ofloxacin, 400 mg twice daily for 10 days, versus intramuscular cefoxitin, 2 gm, plus oral probenecid, 1 gm, followed by oral doxycycline, 100 mg twice daily for 10 days, in the outpatient treatment of uncomplicated acute salpingitis." | 5.07 | A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. ( Bawdon, RE; Cox, SM; Heard, MC; Nobles, BJ; Theriot, SK; Wendel, GD, 1991) |
| "We compared the safety and efficacies of ofloxacin and trimethoprim-sulfamethoxazole for the treatment of acute uncomplicated cystitis in women enrolled in a multicenter study." | 5.06 | Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis. ( Hooton, TM; Johnson, C; Latham, RH; Roberts, PL; Stamm, WE; Wong, ES, 1989) |
| "Ofloxacin (OFLX) was administered to 236 female patients with acute cystitis." | 5.06 | [Clinical evaluation of ofloxacin in the treatment of acute cystitis]. ( Koyanagi, T; Kubota, M; Kumagai, A; Maru, A; Nantani, M; Sakakibara, N; Sakashita, S; Togashi, M; Tsubo, S; Yamazaki, H, 1987) |
| "We report an acute case of hepatitis following treatment with levofloxacin for pneumonia." | 3.76 | Acute hepatitis associated with the use of levofloxacin. ( Figueira-Coelho, J; Mendonça, P; Neta, J; Neves-Costa, J; Pereira, O; Picado, B, 2010) |
| "We report a case of lethal hepatitis possibly/probably associated with levofloxacin, doxy-cycline, and naproxen in a patient with acute M pneumoniae infection." | 3.75 | Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. ( Andrade, RJ; Carrascosa, MF; Caviedes, JR; Lavín, AC; Lucena, MI; Mones, JC; Rivero, AP; Serrano, VB, 2009) |
| "The objective of this study was to assess the in vitro activity of levofloxacin compared to other antibiotics against Escherichia coli strains isolated from female patients with acute pyelonephritis in 23 French hospitals in 2005." | 3.74 | [In vitro activity of levofloxacin against Escherichia coli strains in acute pyelonephritis, in France in 2005]. ( Dib-Smahi, C; Lascols, C; Soussy, CJ, 2007) |
| "A previous study found that a single 2-g dose of azithromycin extended release (AZ-ER) was as efficacious as 10 days of levofloxacin (LFX) 500 mg QD in adults with acute bacterial rhinosinusitis (ABRS)." | 3.74 | Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial. ( de Caprariis, PJ; Marple, BF; Reisman, A; Roberts, CS, 2007) |
| "Imipenem, levofloxacin or saline were administered to rats with caerulein induced pancreatitis." | 3.73 | Effects of selected antibiotics on pancreatitis induced liver and pulmonary injury. ( Coker, A; Coker, C; Erkan, N; Onek, T; Sağol, O; Zeytunlu, M, 2005) |
| "The PharMetrics Patient-Centric claims database was searched over a 3-year period for episodes of acute rhinosinusitis treated within 5 days with moxifloxacin or levofloxacin." | 3.73 | Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges. ( Friedman, HS; Keating, KN; Perfetto, EM, 2006) |
| "The appropriate administration method of levofloxacin in relation to symptoms was investigated by following up 2,353 patients prescribed either levofloxacin (300 mg divided into 3 doses) or 400 mg (divided into 2 doses) for the treatment of acute upper respiratory tract infection accompanied by fever (temperature (> or = 38 degrees C) of suspected bacterial infection." | 3.72 | [Use of the antibacterial agent levofloxacin for acute upper respiratory tract infection accompanied by fever (> or = 38 degrees C)]. ( Matsumoto, T; Odagiri, S; Uchino, K; Yamaguchi, H; Yokoyama, H, 2003) |
| "Studies of acute exacerbations of chronic bronchitis (EXCB) included in the approval documents of levofloxacin (LVF) were reviewed in light of the good conditions of use defined by the French marketing approval and the AFSSAPS recommendations." | 3.72 | [Efficacy of levofloxacin in the treatment of acute exacerbation of chronic bronchitis in patients with risk factors]. ( Brumpt, I; Veyssier, P; Zuck, P, 2004) |
| "THE EFFICACY OF LEVOFLOXACIN: In treating community-acquired pneumonia (CAP) has been assessed during 5 large clinical trials (including 4 controlled randomized trials)." | 3.71 | [Update on the role of levofloxacin in the management of acute community-acquired pneumonia]. ( Bru, JP, 2002) |
| "We investigated the use of an ofloxacin-impregnated bioabsorbable composite for the prevention of acute Staphylococcus aureus osteomyelitis." | 3.70 | Prophylaxis of acute osteomyelitis with absorbable ofloxacin-impregnated beads. ( Kourea, HP; Nicolau, DP; Nie, L; Nightingale, CH; Tessier, PR, 1998) |
| "Two patients with acute leukemia developed Escherichia coli bacteremia while receiving oral ofloxacin for antibacterial prophylaxis during profound neutropenia." | 3.69 | Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients. ( Andriof, E; Kern, WV; Markus, A, 1994) |
| " In a murine model of hematogenous pyelonephritis, the in vivo efficacies of levofloxacin and ciprofloxacin were evaluated against two methicillin-susceptible and two methicillin-resistant S." | 3.69 | In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains. ( Barrett, JF; Frosco, MB; Kulwich, BA; Licata, L; Melton, JL; Stewart, FP, 1996) |
| "We attempted to define the microbiologic characteristics of acute salpingitis in women presenting to an urban emergency department with pelvic inflammatory disease and to determine the effectiveness of ofloxacin in treating this disease." | 3.68 | Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. ( Brockwell, NJ; Dalton, HP; Soper, DE, 1992) |
| "We have compared the efficacy of temafloxacin against Streptococcus pneumoniae in experimental murine pneumonia models with that of ofloxacin and ciprofloxacin." | 3.68 | Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin. ( Azoulay-Dupuis, E; Bedos, JP; Pocidalo, JJ; Vallée, E, 1991) |
| "In a prospective study, 70 men suffering from uncomplicated acute unilateral epididymitis were treated initially with 2 x 200 mg ofloxacin p." | 3.68 | [Initial therapy of acute unilateral epididymitis using ofloxacin. I. Clinical and microbiological findings]. ( Friedrich, HJ; Garbe, C; Harbrecht, J; Kleinschmidt, K; Schiefer, HG; Weidner, W; Weissbach, L, 1990) |
| "The aim of this study was to assess the clinical efficacy of a combination of penicillin G and ofloxacin in the treatment of community acquired pneumonia." | 3.68 | [The combination of penicillin G and ofloxacin: a response to the empirical treatment of community acquired pneumonia]. ( Canton, P; Dopff, C; Dureux, JB; Gerard, A; May, T; Mertes, PM; Nace, L; Preiss, MA; Voiriot, P, 1990) |
| "The effect of a single day treatment with 600 mg norfloxacin 600 mg ofloxacin or 1,920 mg trimethoprim-sulfamethoxazol was determined on 114 patients with acute cystitis." | 3.67 | [Single day treatment in acute cystitis]. ( Kawaguchi, K; Yamaguchi, K, 1988) |
| "After ascertaining the bacterial spectrum in 105 patients with Otitis media acutissima, Otitis media chronica mesotympanalis and Otitis media chronica epitympanalis, the efficacy of oral therapy with ofloxacin in five patients from each of these groups was assessed." | 3.67 | [Ofloxacin in the conservative therapy of acute and chronic otitis media--a preliminary clinical report of experiences]. ( Lenarz, T, 1986) |
| "After ascertaining the bacterial spectrum in 210 patients with Otitis media acuta, Otitis media chronica mesotympanalis and Otitis media chronica epitympanalis, the clinical efficacy of oral therapy with ofloxacin in 40 patients from each of these groups was assessed." | 3.67 | Ofloxacin in oral chemotherapy of acute and chronic otitis media. ( Lenarz, T, 1986) |
| "Fifty-three patients with urinary tract infections (UTI) were treated with Ofloxacin, a new oral synthetic antimicrobial agent, and its clinical efficacy was studied." | 3.67 | [Clinical study of ofloxacin (OFLX) on urinary tract infections]. ( Inada, F; Inagaki, N; Miyata, M; Mizunaga, M; Morikawa, M; Okamura, K; Osanai, H; Yachiku, S, 1987) |
| "In this study, 20 men suffering from acute nongonococcal epididymitis were treated with ofloxacin 200mg bid given orally for 2 weeks." | 3.67 | Acute nongonococcal epididymitis. Aetiological and therapeutic aspects. ( Garbe, C; Schiefer, HG; Weidner, W, 1987) |
| "Levofloxacin reduced the bacterial infections and delays the onset of fever in chemotherapy-induced neutropenia especially in short duration (< 7 days)." | 2.74 | Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia. ( Khan, MA; Rahman, MM, 2009) |
| "Acute diarrhea is a common disease worldwide and in Israel, a Mediterranean country." | 2.72 | Single-dose quinolone treatment in acute gastroenteritis. ( Ben-Valid, E; Hay, E; Kogan, E; Polishchuk, I; Reitblat, T; Weiler, Z; Zamir, D, 2006) |
| "Ciprofloxacin/dexamethasone treatment is also superior to improvement in clinical response by visit, absence of otorrhea by visit, and reduction of otorrhea volume by visit." | 2.71 | Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. ( Anon, JB; Conroy, PJ; Dupre, SJ; Hogg, G; Kreisler, LS; Lanier, B; McLean, C; Potts, S; Reese, B; Roland, PS; Stroman, DW; Wall, GM, 2004) |
| "Levofloxacin is a fluoroquinolone antimicrobial agent for which pharmacodynamic relationships between the maximum serum antibiotic concentration (Cmax)/minimum inhibitory concentration (MIC) ratio and/or the area under the serum concentration-time curve during a 24-h dosing period (AUC(0-24))/MIC ratio and clinical and/or microbiological outcomes have been developed." | 2.71 | Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis. ( Blasi, F; Cazzola, M; Donnarumma, G; Marchetti, F; Matera, MG; Sanduzzi, A; Tufano, MA, 2005) |
| "Ofloxacin has not been associated with ototoxicity in animal models or in children participating in the clinical trials." | 2.70 | Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes. ( Goldblatt, EL, 2001) |
| "Ofloxacin was used in the complex therapy of acute inflammatory diseases of the uterus and uterine appendages." | 2.68 | [Comparative evaluation of the effectiveness of ofloxacin in comprehensive treatment of acute inflammatory diseases of the uterus and uterine appendages]. ( Denisova, EN; Evseev, AA; Savel'eva, GM, 1996) |
| "Ofloxacin appears to be an appropriate antibiotic for short term therapy of acute, uncomplicated, lower urinary tract infections, comparing favourably with trimethoprim-sulphamethoxazole treatment in this study." | 2.66 | Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis. ( Bjertnaes, A; Block, JM; Hafstad, PE; Holte, M; Ottemo, I; Peterson, LE; Rolstad, T; Svarva, PL; Walstad, RA, 1987) |
| "Uncomplicated acute cystitis is one of the most common bacterial infections in adults." | 2.43 | Quinolones for uncomplicated acute cystitis in women. ( Andreeva, I; Rafalsky, V; Rjabkova, E, 2006) |
| "Patients who are treated for acute leukemia should be offered prophylaxis with ciprofloxacin or levofloxacin." | 2.43 | Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions. ( Bucaneve, G; Cullen, M; Fraser, A; Gafter-Gvili, A; Kern, WV; Leibovici, L; Paul, M, 2006) |
| "Levofloxacine is a fluoroquinolone presenting good anti-pneumococcal activity, including against strains with reduced sensitivity to penicillin." | 2.42 | [Levofloxacine for the treatment of pneumococcal pneumonia: results of a meta-analysis]. ( Bru, JP; Leophonte, P; Veyssier, P, 2003) |
| " Lead optimization resulted in the identification of potent compounds with improved oral bioavailability and reduced cardiac ion channel liability." | 1.40 | Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis. ( Achar, V; Arora, U; Awasthy, D; Bharath, S; Bheemarao, U; Chinnapattu, M; Coulson, M; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghosh, A; Hameed P, S; Hoffner, S; Humnabadkar, V; Kaur, P; Kumar K N, M; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Menasinakai, S; Mukherjee, K; Nandishaiah, R; Narayan, C; Panduga, V; Patil, V; Puttur, J; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Sharma, U; Shinde, V; Solapure, S; Waterson, D; Werngren, J, 2014) |
| "The empiric treatment of acute pyelonephritis (APN) with third generation cephalosporins (3GC) or fluoroquinolones (FQ) has been challenged by Escherichia coli resistance reported by community surveillance networks." | 1.40 | Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors. ( Caron, F; Choplin-Renard, J; Etienne, M; Pestel-Caron, M; Van Elslande, H, 2014) |
| "To report a case of spontaneous bleb formation in a presumed pellucid marginal corneal degeneration with acute hydrops." | 1.39 | Spontaneous bleb formation in a presumed pellucid marginal corneal degeneration with acute hydrops. ( Higashiura, R; Inoue, T; Maeda, N; Ohashi, Y; Suzuki, T; Toriyama, K, 2013) |
| "Acute phlegmonous gastritis is an uncommon disease, often fatal condition characterized by suppurative bacterial infection of the gastric wall." | 1.37 | [A case of acute phlegmonous gastritis causing gastroparesis and cured with medical treatment alone]. ( Kim, JS; Kim, NY; Lee, KJ; Park, JS; Yun, HK, 2011) |
| "Although it is rare, acute pancreatitis must be considered when evaluating patients presenting with abdominal pain and/or ascites in the postpartum period." | 1.33 | Ascites in the puerperium: a missed diagnosis of acute postpartum pancreatitis. ( Fakokunde, A; Gyang, A; Kalu, E; Whitlow, B, 2005) |
| "A 70-year-old man was hospitalized for septic shock with acute respiratory and renal failure after intravesical instillation of BCG, which was identified in the gastric aspiration sample." | 1.33 | [Acute respiratory failure and septic shock induced by Mycobacterium bovis. A rare side effect of intravesical BCG therapy]. ( Dequin, PF; Garot, D; Legras, A; Mercier, E; Narciso, B; Perrotin, D; Rival, G, 2006) |
| "Levofloxacin is a fluoroquinolone antibiotic commonly used to treat respiratory, urinary tract, skin and soft-tissue infections." | 1.32 | Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient. ( Lee, CH; Schwalm, JD, 2003) |
| "Acute epididymitis is increasing in men aged 35 years or under due to sexually-transmitted Chlamydia trachomatis." | 1.32 | Management of acute epididymitis: are European guidelines being followed? ( Adamson, AS; Breitenfeldt, N; Drury, NE; Dyer, JP; Harrison, GS, 2004) |
| "The patient was diagnosed with acute tubulointerstitial nephritis caused by cefdinir." | 1.31 | Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure. ( Fujiwara, T; Hiramori, K; Kawamura, M; Kimura, Y; Maesawa, C; Owada, M, 2001) |
| "We have assessed levofloxacin penetration in cerebrospinal fluid (CSF) and the liquor-to-plasma ratio (C(L)/C(P)) at 2 hours after dosing in 5 patients with spontaneous acute bacterial meningitis." | 1.31 | Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis. ( Baraldo, M; Furlanut, M; Giobbia, M; Pea, F; Scotton, PG; Vaglia, A, 2001) |
| "Acute suppurative parotitis is a rare infection which usually occurs in hospitalized patients." | 1.29 | [Acute suppurative parotitis caused by Pseudomonas aeruginosa]. ( Mouallem, M; Regev, G, 1994) |
| " every 6 h for one day only, while 4 patients with acute peritonitis were treated with this same dosage every 4 h for 3 days, then every 6 h for the next 7 days." | 1.28 | Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients. ( Borner, K; Conrad, W; Hain, H; Kampf, D, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (9.21) | 18.7374 |
| 1990's | 43 (28.29) | 18.2507 |
| 2000's | 79 (51.97) | 29.6817 |
| 2010's | 15 (9.87) | 24.3611 |
| 2020's | 1 (0.66) | 2.80 |
| Authors | Studies |
|---|---|
| Amir, M | 1 |
| Kumar, H | 1 |
| Javed, SA | 1 |
| Hameed P, S | 1 |
| Patil, V | 1 |
| Solapure, S | 1 |
| Sharma, U | 1 |
| Madhavapeddi, P | 1 |
| Raichurkar, A | 1 |
| Chinnapattu, M | 1 |
| Manjrekar, P | 1 |
| Shanbhag, G | 1 |
| Puttur, J | 1 |
| Shinde, V | 1 |
| Menasinakai, S | 1 |
| Rudrapatana, S | 1 |
| Achar, V | 1 |
| Awasthy, D | 1 |
| Nandishaiah, R | 1 |
| Humnabadkar, V | 1 |
| Ghosh, A | 1 |
| Narayan, C | 1 |
| Ramya, VK | 1 |
| Kaur, P | 1 |
| Sharma, S | 1 |
| Werngren, J | 1 |
| Hoffner, S | 1 |
| Panduga, V | 1 |
| Kumar, CN | 1 |
| Reddy, J | 1 |
| Kumar K N, M | 1 |
| Ganguly, S | 1 |
| Bharath, S | 1 |
| Bheemarao, U | 1 |
| Mukherjee, K | 1 |
| Arora, U | 1 |
| Gaonkar, S | 1 |
| Coulson, M | 1 |
| Waterson, D | 1 |
| Sambandamurthy, VK | 1 |
| de Sousa, SM | 1 |
| Nguépy Keubo, FR | 1 |
| Mboua, PC | 1 |
| Djifack Tadongfack, T | 1 |
| Fokouong Tchoffo, E | 1 |
| Tasson Tatang, C | 1 |
| Ide Zeuna, J | 1 |
| Noupoue, EM | 1 |
| Tsoplifack, CB | 1 |
| Folefack, GO | 1 |
| Kettani, M | 1 |
| Bandelier, P | 1 |
| Huo, J | 1 |
| Li, H | 4 |
| Yu, D | 1 |
| Arulsamy, N | 1 |
| AlAbbad, S | 1 |
| Sardot, T | 1 |
| Lekashvili, O | 1 |
| Decato, D | 1 |
| Lelj, F | 1 |
| Alexander Ross, JB | 1 |
| Rosenberg, E | 1 |
| Nazir, H | 1 |
| Muthuswamy, N | 1 |
| Louis, C | 1 |
| Jose, S | 1 |
| Prakash, J | 1 |
| Buan, MEM | 1 |
| Flox, C | 1 |
| Chavan, S | 1 |
| Shi, X | 1 |
| Kauranen, P | 1 |
| Kallio, T | 1 |
| Maia, G | 1 |
| Tammeveski, K | 1 |
| Lymperopoulos, N | 1 |
| Carcadea, E | 1 |
| Veziroglu, E | 1 |
| Iranzo, A | 1 |
| M Kannan, A | 1 |
| Arunamata, A | 1 |
| Tacy, TA | 1 |
| Kache, S | 1 |
| Mainwaring, RD | 1 |
| Ma, M | 1 |
| Maeda, K | 1 |
| Punn, R | 1 |
| Noguchi, S | 1 |
| Hahn, S | 3 |
| Iwasa, Y | 3 |
| Ling, J | 2 |
| Voccio, JP | 2 |
| Kim, Y | 3 |
| Song, J | 3 |
| Bascuñán, J | 2 |
| Chu, Y | 1 |
| Tomita, M | 1 |
| Cazorla, M | 1 |
| Herrera, E | 1 |
| Palomeque, E | 1 |
| Saud, N | 1 |
| Hoplock, LB | 1 |
| Lobchuk, MM | 1 |
| Lemoine, J | 1 |
| Li, X | 10 |
| Henson, MA | 1 |
| Unsihuay, D | 1 |
| Qiu, J | 1 |
| Swaroop, S | 1 |
| Nagornov, KO | 1 |
| Kozhinov, AN | 1 |
| Tsybin, YO | 1 |
| Kuang, S | 1 |
| Laskin, J | 1 |
| Zin, NNINM | 1 |
| Mohamad, MN | 1 |
| Roslan, K | 1 |
| Abdul Wafi, S | 1 |
| Abdul Moin, NI | 1 |
| Alias, A | 1 |
| Zakaria, Y | 1 |
| Abu-Bakar, N | 1 |
| Naveed, A | 1 |
| Jilani, K | 1 |
| Siddique, AB | 1 |
| Akbar, M | 1 |
| Riaz, M | 1 |
| Mushtaq, Z | 1 |
| Sikandar, M | 1 |
| Ilyas, S | 1 |
| Bibi, I | 1 |
| Asghar, A | 1 |
| Rasool, G | 1 |
| Irfan, M | 1 |
| Li, XY | 1 |
| Zhao, S | 1 |
| Fan, XH | 1 |
| Chen, KP | 1 |
| Hua, W | 1 |
| Liu, ZM | 1 |
| Xue, XD | 1 |
| Zhou, B | 1 |
| Zhang, S | 2 |
| Xing, YL | 1 |
| Chen, MA | 1 |
| Sun, Y | 1 |
| Neradilek, MB | 1 |
| Wu, XT | 1 |
| Zhang, D | 2 |
| Huang, W | 2 |
| Cui, Y | 1 |
| Yang, QQ | 1 |
| Li, HW | 1 |
| Zhao, XQ | 1 |
| Hossein Rashidi, B | 1 |
| Tarafdari, A | 1 |
| Ghazimirsaeed, ST | 1 |
| Shahrokh Tehraninezhad, E | 1 |
| Keikha, F | 1 |
| Eslami, B | 1 |
| Ghazimirsaeed, SM | 1 |
| Jafarabadi, M | 1 |
| Silvani, Y | 1 |
| Lovita, AND | 1 |
| Maharani, A | 1 |
| Wiyasa, IWA | 1 |
| Sujuti, H | 1 |
| Ratnawati, R | 1 |
| Raras, TYM | 1 |
| Lemin, AS | 1 |
| Rahman, MM | 2 |
| Pangarah, CA | 1 |
| Kiyu, A | 1 |
| Zeng, C | 2 |
| Du, H | 1 |
| Lin, D | 1 |
| Jalan, D | 1 |
| Rubagumya, F | 1 |
| Hopman, WM | 1 |
| Vanderpuye, V | 1 |
| Lopes, G | 1 |
| Seruga, B | 1 |
| Booth, CM | 1 |
| Berry, S | 1 |
| Hammad, N | 1 |
| Sajo, EA | 1 |
| Okunade, KS | 1 |
| Olorunfemi, G | 1 |
| Rabiu, KA | 1 |
| Anorlu, RI | 1 |
| Xu, C | 2 |
| Xiang, Y | 1 |
| Xu, X | 1 |
| Zhou, L | 2 |
| Dong, X | 1 |
| Tang, S | 1 |
| Gao, XC | 1 |
| Wei, CH | 1 |
| Zhang, RG | 1 |
| Cai, Q | 1 |
| He, Y | 1 |
| Tong, F | 1 |
| Dong, JH | 1 |
| Wu, G | 1 |
| Dong, XR | 1 |
| Tang, X | 1 |
| Tao, F | 1 |
| Xiang, W | 1 |
| Zhao, Y | 2 |
| Jin, L | 1 |
| Tao, H | 1 |
| Lei, Y | 1 |
| Gan, H | 1 |
| Huang, Y | 1 |
| Chen, Y | 3 |
| Chen, L | 3 |
| Shan, A | 1 |
| Zhao, H | 2 |
| Wu, M | 2 |
| Ma, Q | 1 |
| Wang, J | 5 |
| Zhang, E | 1 |
| Zhang, J | 3 |
| Li, Y | 5 |
| Xue, F | 1 |
| Deng, L | 1 |
| Liu, L | 2 |
| Yan, Z | 2 |
| Wang, Y | 2 |
| Meng, J | 1 |
| Chen, G | 2 |
| Anastassiadou, M | 1 |
| Bernasconi, G | 1 |
| Brancato, A | 1 |
| Carrasco Cabrera, L | 1 |
| Greco, L | 1 |
| Jarrah, S | 1 |
| Kazocina, A | 1 |
| Leuschner, R | 1 |
| Magrans, JO | 1 |
| Miron, I | 1 |
| Nave, S | 1 |
| Pedersen, R | 1 |
| Reich, H | 1 |
| Rojas, A | 1 |
| Sacchi, A | 1 |
| Santos, M | 1 |
| Theobald, A | 1 |
| Vagenende, B | 1 |
| Verani, A | 1 |
| Du, L | 1 |
| Liu, X | 1 |
| Ren, Y | 1 |
| Li, J | 7 |
| Li, P | 1 |
| Jiao, Q | 1 |
| Meng, P | 1 |
| Wang, F | 2 |
| Wang, YS | 1 |
| Wang, C | 3 |
| Zhou, X | 2 |
| Wang, W | 1 |
| Wang, S | 2 |
| Hou, J | 1 |
| Zhang, A | 1 |
| Lv, B | 1 |
| Gao, C | 1 |
| Pang, D | 1 |
| Lu, K | 1 |
| Ahmad, NH | 1 |
| Wang, L | 1 |
| Zhu, J | 2 |
| Zhang, L | 2 |
| Zhuang, T | 1 |
| Tu, J | 1 |
| Zhao, Z | 1 |
| Qu, Y | 1 |
| Yao, H | 1 |
| Wang, X | 5 |
| Lee, DF | 1 |
| Shen, J | 3 |
| Wen, L | 1 |
| Huang, G | 2 |
| Xie, X | 1 |
| Zhao, Q | 1 |
| Hu, W | 1 |
| Zhang, Y | 4 |
| Wu, X | 1 |
| Lu, J | 2 |
| Li, M | 1 |
| Li, W | 2 |
| Wu, W | 1 |
| Du, F | 1 |
| Ji, H | 1 |
| Yang, X | 2 |
| Xu, Z | 1 |
| Wan, L | 1 |
| Wen, Q | 1 |
| Cho, CH | 1 |
| Zou, C | 1 |
| Xiao, Z | 1 |
| Liao, J | 1 |
| Su, X | 1 |
| Bi, Z | 1 |
| Su, Q | 1 |
| Huang, H | 1 |
| Wei, Y | 2 |
| Gao, Y | 2 |
| Na, KJ | 1 |
| Choi, H | 1 |
| Oh, HR | 1 |
| Kim, YH | 1 |
| Lee, SB | 1 |
| Jung, YJ | 1 |
| Koh, J | 1 |
| Park, S | 1 |
| Lee, HJ | 1 |
| Jeon, YK | 1 |
| Chung, DH | 1 |
| Paeng, JC | 1 |
| Park, IK | 1 |
| Kang, CH | 1 |
| Cheon, GJ | 1 |
| Kang, KW | 1 |
| Lee, DS | 1 |
| Kim, YT | 1 |
| Pajuelo-Lozano, N | 1 |
| Alcalá, S | 1 |
| Sainz, B | 1 |
| Perona, R | 1 |
| Sanchez-Perez, I | 1 |
| Logotheti, S | 1 |
| Marquardt, S | 1 |
| Gupta, SK | 1 |
| Richter, C | 1 |
| Edelhäuser, BAH | 1 |
| Engelmann, D | 1 |
| Brenmoehl, J | 1 |
| Söhnchen, C | 1 |
| Murr, N | 1 |
| Alpers, M | 1 |
| Singh, KP | 1 |
| Wolkenhauer, O | 1 |
| Heckl, D | 1 |
| Spitschak, A | 1 |
| Pützer, BM | 1 |
| Liao, Y | 1 |
| Cheng, J | 1 |
| Kong, X | 1 |
| Li, S | 1 |
| Zhang, M | 4 |
| Zhang, H | 1 |
| Yang, T | 2 |
| Dong, Y | 1 |
| Xu, Y | 1 |
| Yuan, Z | 1 |
| Cao, J | 1 |
| Zheng, Y | 1 |
| Luo, Z | 1 |
| Mei, Z | 1 |
| Yao, Y | 1 |
| Liu, Z | 2 |
| Liang, C | 1 |
| Yang, H | 1 |
| Song, Y | 1 |
| Yu, K | 1 |
| Zhu, C | 1 |
| Huang, Z | 1 |
| Qian, J | 1 |
| Ge, J | 1 |
| Hu, J | 2 |
| Wang, H | 2 |
| Liu, Y | 4 |
| Mi, Y | 1 |
| Kong, H | 1 |
| Xi, D | 1 |
| Yan, W | 1 |
| Luo, X | 1 |
| Ning, Q | 1 |
| Chang, X | 2 |
| Zhang, T | 2 |
| Wang, Q | 2 |
| Rathore, MG | 1 |
| Reddy, K | 1 |
| Chen, H | 1 |
| Shin, SH | 1 |
| Ma, WY | 1 |
| Bode, AM | 1 |
| Dong, Z | 1 |
| Mu, W | 1 |
| Liu, C | 3 |
| Gao, F | 1 |
| Qi, Y | 1 |
| Lu, H | 1 |
| Zhang, X | 4 |
| Cai, X | 1 |
| Ji, RY | 1 |
| Hou, Y | 3 |
| Tian, J | 2 |
| Shi, Y | 1 |
| Ying, S | 1 |
| Tan, M | 1 |
| Feng, G | 1 |
| Kuang, Y | 1 |
| Chen, D | 1 |
| Wu, D | 3 |
| Zhu, ZQ | 1 |
| Tang, HX | 1 |
| Shi, ZE | 1 |
| Kang, J | 1 |
| Liu, Q | 1 |
| Qi, J | 2 |
| Mu, J | 1 |
| Cong, Z | 1 |
| Chen, S | 2 |
| Fu, D | 1 |
| Li, Z | 2 |
| Celestrin, CP | 1 |
| Rocha, GZ | 1 |
| Stein, AM | 1 |
| Guadagnini, D | 1 |
| Tadelle, RM | 1 |
| Saad, MJA | 1 |
| Oliveira, AG | 1 |
| Bianconi, V | 1 |
| Bronzo, P | 1 |
| Banach, M | 1 |
| Sahebkar, A | 1 |
| Mannarino, MR | 1 |
| Pirro, M | 1 |
| Patsourakos, NG | 1 |
| Kouvari, M | 1 |
| Kotidis, A | 1 |
| Kalantzi, KI | 1 |
| Tsoumani, ME | 1 |
| Anastasiadis, F | 1 |
| Andronikos, P | 1 |
| Aslanidou, T | 1 |
| Efraimidis, P | 1 |
| Georgiopoulos, A | 1 |
| Gerakiou, K | 1 |
| Grigoriadou-Skouta, E | 1 |
| Grigoropoulos, P | 1 |
| Hatzopoulos, D | 1 |
| Kartalis, A | 1 |
| Lyras, A | 1 |
| Markatos, G | 1 |
| Mikrogeorgiou, A | 1 |
| Myroforou, I | 1 |
| Orkopoulos, A | 1 |
| Pavlidis, P | 1 |
| Petras, C | 1 |
| Riga, M | 1 |
| Skouloudi, M | 1 |
| Smyrnioudis, N | 1 |
| Thomaidis, K | 1 |
| Tsikouri, GE | 1 |
| Tsikouris, EI | 1 |
| Zisimos, K | 1 |
| Vavoulis, P | 1 |
| Vitali, MG | 1 |
| Vitsas, G | 1 |
| Vogiatzidis, C | 1 |
| Chantanis, S | 1 |
| Fousas, S | 1 |
| Panagiotakos, DB | 1 |
| Tselepis, AD | 1 |
| Jungen, C | 1 |
| Alken, FA | 1 |
| Eickholt, C | 1 |
| Scherschel, K | 1 |
| Kuklik, P | 1 |
| Klatt, N | 1 |
| Schwarzl, J | 1 |
| Moser, J | 1 |
| Jularic, M | 1 |
| Akbulak, RO | 1 |
| Schaeffer, B | 1 |
| Willems, S | 1 |
| Meyer, C | 1 |
| Nowak, JK | 1 |
| Szczepanik, M | 1 |
| Trypuć, M | 1 |
| Pogorzelski, A | 1 |
| Bobkowski, W | 1 |
| Grytczuk, M | 1 |
| Minarowska, A | 1 |
| Wójciak, R | 1 |
| Walkowiak, J | 1 |
| Lu, Y | 1 |
| Xi, J | 1 |
| Li, C | 1 |
| Chen, W | 2 |
| Hu, X | 1 |
| Zhang, F | 1 |
| Wei, H | 1 |
| Wang, Z | 1 |
| Gurzu, S | 1 |
| Jung, I | 1 |
| Sugimura, H | 2 |
| Stefan-van Staden, RI | 1 |
| Yamada, H | 1 |
| Natsume, H | 1 |
| Iwashita, Y | 1 |
| Szodorai, R | 1 |
| Szederjesi, J | 1 |
| Yari, D | 1 |
| Ehsanbakhsh, Z | 1 |
| Validad, MH | 1 |
| Langroudi, FH | 1 |
| Esfandiari, H | 1 |
| Prager, A | 1 |
| Hassanpour, K | 1 |
| Kurup, SP | 1 |
| Mets-Halgrimson, R | 1 |
| Yoon, H | 1 |
| Zeid, JL | 1 |
| Mets, MB | 1 |
| Rahmani, B | 1 |
| Araujo-Castillo, RV | 1 |
| Culquichicón, C | 1 |
| Solis Condor, R | 1 |
| Efendi, F | 1 |
| Sebayang, SK | 1 |
| Astutik, E | 1 |
| Hadisuyatmana, S | 1 |
| Has, EMM | 1 |
| Kuswanto, H | 1 |
| Foroutan, T | 1 |
| Ahmadi, F | 1 |
| Moayer, F | 1 |
| Khalvati, S | 1 |
| Zhang, Q | 2 |
| Lyu, Y | 1 |
| Huang, J | 1 |
| Yu, N | 1 |
| Wen, Z | 1 |
| Hou, H | 1 |
| Zhao, T | 1 |
| Gupta, A | 1 |
| Khosla, N | 1 |
| Govindasamy, V | 1 |
| Saini, A | 1 |
| Annapurna, K | 1 |
| Dhakate, SR | 1 |
| Akkaya, Ö | 1 |
| Chandgude, AL | 1 |
| Dömling, A | 1 |
| Harnett, J | 1 |
| Oakes, K | 1 |
| Carè, J | 1 |
| Leach, M | 1 |
| Brown, D | 1 |
| Cramer, H | 1 |
| Pinder, TA | 1 |
| Steel, A | 1 |
| Anheyer, D | 1 |
| Cantu, J | 1 |
| Valle, J | 1 |
| Flores, K | 1 |
| Gonzalez, D | 1 |
| Valdes, C | 1 |
| Lopez, J | 1 |
| Padilla, V | 1 |
| Alcoutlabi, M | 1 |
| Parsons, J | 1 |
| Núñez, K | 1 |
| Hamed, M | 1 |
| Fort, D | 1 |
| Bruce, D | 1 |
| Thevenot, P | 1 |
| Cohen, A | 1 |
| Weber, P | 1 |
| Menezes, AMB | 1 |
| Gonçalves, H | 1 |
| Perez-Padilla, R | 1 |
| Jarvis, D | 1 |
| de Oliveira, PD | 1 |
| Wehrmeister, FC | 1 |
| Mir, S | 1 |
| Wong, J | 1 |
| Ryan, CM | 1 |
| Bellingham, G | 1 |
| Singh, M | 2 |
| Waseem, R | 1 |
| Eckert, DJ | 1 |
| Chung, F | 1 |
| Hegde, H | 1 |
| Shimpi, N | 1 |
| Panny, A | 1 |
| Glurich, I | 1 |
| Christie, P | 1 |
| Acharya, A | 1 |
| English, KL | 1 |
| Downs, M | 1 |
| Goetchius, E | 1 |
| Buxton, R | 1 |
| Ryder, JW | 1 |
| Ploutz-Snyder, R | 1 |
| Guilliams, M | 1 |
| Scott, JM | 1 |
| Ploutz-Snyder, LL | 1 |
| Martens, C | 1 |
| Goplen, FK | 1 |
| Aasen, T | 1 |
| Gjestad, R | 1 |
| Nordfalk, KF | 1 |
| Nordahl, SHG | 1 |
| Inoue, T | 2 |
| Soshi, S | 1 |
| Kubota, M | 2 |
| Marumo, K | 1 |
| Mortensen, NP | 1 |
| Caffaro, MM | 1 |
| Patel, PR | 2 |
| Uddin, MJ | 1 |
| Aravamudhan, S | 1 |
| Sumner, SJ | 1 |
| Fennell, TR | 1 |
| Gal, RL | 1 |
| Cohen, NJ | 1 |
| Kruger, D | 1 |
| Beck, RW | 1 |
| Bergenstal, RM | 1 |
| Calhoun, P | 1 |
| Cushman, T | 1 |
| Haban, A | 1 |
| Hood, K | 1 |
| Johnson, ML | 1 |
| McArthur, T | 1 |
| Olson, BA | 1 |
| Weinstock, RS | 1 |
| Oser, SM | 1 |
| Oser, TK | 1 |
| Bugielski, B | 1 |
| Strayer, H | 1 |
| Aleppo, G | 1 |
| Maruyama, H | 1 |
| Hirayama, K | 1 |
| Yamashita, M | 1 |
| Ohgi, K | 1 |
| Tsujimoto, R | 1 |
| Takayasu, M | 1 |
| Shimohata, H | 1 |
| Kobayashi, M | 1 |
| Buscagan, TM | 1 |
| Rees, DC | 1 |
| Jaborek, JR | 1 |
| Zerby, HN | 1 |
| Wick, MP | 1 |
| Fluharty, FL | 1 |
| Moeller, SJ | 1 |
| Razavi, P | 1 |
| Dickler, MN | 1 |
| Shah, PD | 1 |
| Toy, W | 1 |
| Brown, DN | 1 |
| Won, HH | 1 |
| Li, BT | 1 |
| Shen, R | 1 |
| Vasan, N | 1 |
| Modi, S | 1 |
| Jhaveri, K | 1 |
| Caravella, BA | 1 |
| Patil, S | 1 |
| Selenica, P | 1 |
| Zamora, S | 1 |
| Cowan, AM | 1 |
| Comen, E | 1 |
| Singh, A | 1 |
| Covey, A | 1 |
| Berger, MF | 1 |
| Hudis, CA | 1 |
| Norton, L | 1 |
| Nagy, RJ | 1 |
| Odegaard, JI | 1 |
| Lanman, RB | 1 |
| Solit, DB | 1 |
| Robson, ME | 1 |
| Lacouture, ME | 1 |
| Brogi, E | 1 |
| Reis-Filho, JS | 1 |
| Moynahan, ME | 1 |
| Scaltriti, M | 1 |
| Chandarlapaty, S | 1 |
| Papouskova, K | 1 |
| Moravcova, M | 1 |
| Masrati, G | 1 |
| Ben-Tal, N | 1 |
| Sychrova, H | 1 |
| Zimmermannova, O | 1 |
| Fang, J | 1 |
| Fan, Y | 1 |
| Luo, T | 2 |
| Su, H | 1 |
| Tsetseris, L | 1 |
| Anthopoulos, TD | 1 |
| Liu, SF | 1 |
| Zhao, K | 1 |
| Sacan, O | 1 |
| Turkyilmaz, IB | 1 |
| Bayrak, BB | 1 |
| Mutlu, O | 1 |
| Akev, N | 1 |
| Yanardag, R | 1 |
| Gruber, S | 1 |
| Kamnoedboon, P | 1 |
| Özcan, M | 1 |
| Srinivasan, M | 1 |
| Jo, YH | 1 |
| Oh, HK | 1 |
| Jeong, SY | 1 |
| Lee, BG | 1 |
| Zheng, J | 1 |
| Guan, H | 1 |
| Li, D | 2 |
| Tan, H | 1 |
| Maji, TK | 1 |
| J R, A | 1 |
| Mukherjee, S | 1 |
| Alexander, R | 1 |
| Mondal, A | 1 |
| Das, S | 1 |
| Sharma, RK | 1 |
| Chakraborty, NK | 1 |
| Dasgupta, K | 1 |
| Sharma, AMR | 1 |
| Hawaldar, R | 1 |
| Pandey, M | 1 |
| Naik, A | 1 |
| Majumdar, K | 1 |
| Pal, SK | 1 |
| Adarsh, KV | 1 |
| Ray, SK | 1 |
| Karmakar, D | 1 |
| Ma, Y | 2 |
| Gao, W | 1 |
| Ma, S | 1 |
| Lin, W | 1 |
| Zhou, T | 1 |
| Wu, T | 1 |
| Wu, Q | 1 |
| Ye, C | 1 |
| He, X | 1 |
| Jiang, F | 1 |
| Yuan, D | 1 |
| Chen, Q | 1 |
| Hong, M | 1 |
| Chen, K | 1 |
| Hussain, M | 1 |
| Razi, SS | 1 |
| Yildiz, EA | 1 |
| Zhao, J | 1 |
| Yaglioglu, HG | 1 |
| Donato, MD | 1 |
| Jiang, J | 1 |
| Jamil, MI | 1 |
| Zhan, X | 1 |
| Chen, F | 1 |
| Cheng, D | 1 |
| Wu, CT | 1 |
| Utsunomiya, T | 1 |
| Ichii, T | 1 |
| Fujinami, S | 1 |
| Nakajima, K | 1 |
| Sanchez, DM | 1 |
| Raucci, U | 1 |
| Ferreras, KN | 1 |
| Martínez, TJ | 1 |
| Mordi, NA | 1 |
| Mordi, IR | 1 |
| Singh, JS | 1 |
| McCrimmon, RJ | 1 |
| Struthers, AD | 1 |
| Lang, CC | 1 |
| Wang, XW | 1 |
| Yuan, LJ | 1 |
| Yang, Y | 1 |
| Chen, WF | 1 |
| Luo, R | 1 |
| Yang, K | 1 |
| Amarasiri, SS | 1 |
| Attanayake, AP | 1 |
| Arawwawala, LDAM | 1 |
| Jayatilaka, KAPW | 1 |
| Mudduwa, LKB | 1 |
| Ogunsuyi, O | 2 |
| Akanni, O | 1 |
| Alabi, O | 1 |
| Alimba, C | 1 |
| Adaramoye, O | 1 |
| Cambier, S | 1 |
| Eswara, S | 1 |
| Gutleb, AC | 1 |
| Bakare, A | 1 |
| Gu, Z | 1 |
| Cong, J | 1 |
| Pellegrini, M | 1 |
| Palmieri, S | 1 |
| Ricci, A | 1 |
| Serio, A | 1 |
| Paparella, A | 1 |
| Lo Sterzo, C | 1 |
| Jadeja, SD | 1 |
| Vaishnav, J | 1 |
| Mansuri, MS | 1 |
| Shah, C | 1 |
| Mayatra, JM | 1 |
| Shah, A | 1 |
| Begum, R | 1 |
| Song, H | 2 |
| Lian, Y | 1 |
| Wan, T | 1 |
| Schultz-Lebahn, A | 1 |
| Skipper, MT | 1 |
| Hvas, AM | 1 |
| Larsen, OH | 1 |
| Hijazi, Z | 1 |
| Granger, CB | 1 |
| Hohnloser, SH | 1 |
| Westerbergh, J | 1 |
| Lindbäck, J | 1 |
| Alexander, JH | 1 |
| Keltai, M | 1 |
| Parkhomenko, A | 1 |
| López-Sendón, JL | 1 |
| Lopes, RD | 1 |
| Siegbahn, A | 1 |
| Wallentin, L | 1 |
| El-Tarabany, MS | 1 |
| Saleh, AA | 1 |
| El-Araby, IE | 1 |
| El-Magd, MA | 1 |
| van Ginkel, MPH | 1 |
| Schijven, MP | 1 |
| van Grevenstein, WMU | 1 |
| Schreuder, HWR | 1 |
| Pereira, EDM | 1 |
| da Silva, J | 1 |
| Carvalho, PDS | 1 |
| Grivicich, I | 1 |
| Picada, JN | 1 |
| Salgado Júnior, IB | 1 |
| Vasques, GJ | 1 |
| Pereira, MADS | 1 |
| Reginatto, FH | 1 |
| Ferraz, ABF | 1 |
| Vasilenko, EA | 1 |
| Gorshkova, EN | 1 |
| Astrakhantseva, IV | 1 |
| Drutskaya, MS | 1 |
| Tillib, SV | 1 |
| Nedospasov, SA | 1 |
| Mokhonov, VV | 1 |
| Nam, YW | 1 |
| Cui, M | 1 |
| Orfali, R | 1 |
| Viegas, A | 1 |
| Nguyen, M | 1 |
| Mohammed, EHM | 1 |
| Zoghebi, KA | 1 |
| Rahighi, S | 1 |
| Parang, K | 1 |
| Patterson, KC | 1 |
| Kahanovitch, U | 1 |
| Gonçalves, CM | 1 |
| Hablitz, JJ | 1 |
| Staruschenko, A | 1 |
| Mulkey, DK | 1 |
| Olsen, ML | 1 |
| Gu, L | 1 |
| Cao, X | 1 |
| Mukhtar, A | 1 |
| Wu, K | 1 |
| Zhang, YY | 1 |
| Zhu, Y | 1 |
| Lu, DZ | 1 |
| Dong, W | 1 |
| Bi, WJ | 1 |
| Feng, XJ | 1 |
| Wen, LM | 1 |
| Sun, H | 1 |
| Qi, MC | 1 |
| Chang, CC | 1 |
| Dinh, TK | 1 |
| Lee, YA | 1 |
| Wang, FN | 1 |
| Sung, YC | 1 |
| Yu, PL | 1 |
| Chiu, SC | 1 |
| Shih, YC | 1 |
| Wu, CY | 1 |
| Huang, YD | 1 |
| Lu, TT | 1 |
| Wan, D | 1 |
| Sakizadeh, J | 1 |
| Cline, JP | 1 |
| Snyder, MA | 1 |
| Kiely, CJ | 1 |
| McIntosh, S | 1 |
| Jiang, X | 1 |
| Cao, JW | 1 |
| Zhao, CK | 1 |
| Yang, R | 1 |
| Zhang, QY | 1 |
| Chen, KJ | 2 |
| Liu, H | 1 |
| He, Z | 1 |
| Chen, B | 1 |
| Wu, J | 1 |
| Du, X | 1 |
| Moore, J | 1 |
| Blank, BR | 1 |
| Eksterowicz, J | 1 |
| Sutimantanapi, D | 1 |
| Yuen, N | 1 |
| Metzger, T | 1 |
| Chan, B | 1 |
| Huang, T | 1 |
| Chen, X | 1 |
| Duong, F | 1 |
| Kong, W | 1 |
| Chang, JH | 1 |
| Sun, J | 1 |
| Zavorotinskaya, T | 1 |
| Ye, Q | 1 |
| Junttila, MR | 1 |
| Ndubaku, C | 1 |
| Friedman, LS | 1 |
| Fantin, VR | 1 |
| Sun, D | 1 |
| Fei, P | 1 |
| Xie, Q | 1 |
| Jiang, Y | 1 |
| Feng, H | 1 |
| Chang, Y | 1 |
| Kang, H | 1 |
| Xing, M | 1 |
| Chen, J | 1 |
| Shao, Z | 1 |
| Yuan, C | 1 |
| Wu, Y | 1 |
| Allan, R | 1 |
| Canham, K | 1 |
| Wallace, R | 1 |
| Singh, D | 1 |
| Ward, J | 1 |
| Cooper, A | 1 |
| Newcomb, C | 1 |
| Nammour, S | 1 |
| El Mobadder, M | 1 |
| Maalouf, E | 1 |
| Namour, M | 1 |
| Namour, A | 1 |
| Rey, G | 1 |
| Matamba, P | 1 |
| Matys, J | 1 |
| Zeinoun, T | 1 |
| Grzech-Leśniak, K | 1 |
| Segabinazi Peserico, C | 1 |
| Garozi, L | 1 |
| Zagatto, AM | 1 |
| Machado, FA | 1 |
| Hirth, JM | 1 |
| Dinehart, EE | 1 |
| Lin, YL | 1 |
| Kuo, YF | 1 |
| Nouri, SS | 1 |
| Ritchie, C | 1 |
| Volow, A | 1 |
| Li, B | 2 |
| McSpadden, S | 1 |
| Dearman, K | 1 |
| Kotwal, A | 1 |
| Sudore, RL | 1 |
| Ward, L | 1 |
| Thakur, A | 1 |
| Kondadasula, SV | 1 |
| Ji, K | 1 |
| Schalk, DL | 1 |
| Bliemeister, E | 1 |
| Ung, J | 1 |
| Aboukameel, A | 1 |
| Casarez, E | 1 |
| Sloane, BF | 1 |
| Lum, LG | 1 |
| Xiao, M | 1 |
| Feng, X | 1 |
| Gao, R | 1 |
| Du, B | 1 |
| Brooks, T | 1 |
| Zwirner, J | 1 |
| Hammer, N | 1 |
| Ondruschka, B | 1 |
| Jermy, M | 1 |
| Luengo, A | 1 |
| Marzo, I | 1 |
| Reback, M | 1 |
| Daubit, IM | 1 |
| Fernández-Moreira, V | 1 |
| Metzler-Nolte, N | 1 |
| Gimeno, MC | 1 |
| Tonchev, I | 1 |
| Heberman, D | 1 |
| Peretz, A | 1 |
| Medvedovsky, AT | 1 |
| Gotsman, I | 1 |
| Rashi, Y | 1 |
| Poles, L | 1 |
| Goland, S | 1 |
| Perlman, GY | 1 |
| Danenberg, HD | 1 |
| Beeri, R | 1 |
| Shuvy, M | 1 |
| Fu, Q | 1 |
| Yang, D | 1 |
| Sarapulova, A | 1 |
| Pang, Q | 1 |
| Meng, Y | 1 |
| Wei, L | 1 |
| Ehrenberg, H | 1 |
| Kim, CC | 1 |
| Jeong, SH | 1 |
| Oh, KH | 1 |
| Nam, KT | 1 |
| Sun, JY | 1 |
| Ning, J | 1 |
| Duan, Z | 1 |
| Kershaw, SV | 1 |
| Rogach, AL | 1 |
| Gao, Z | 1 |
| Wang, T | 1 |
| Li, Q | 1 |
| Cao, T | 1 |
| Guo, L | 1 |
| Fu, Y | 1 |
| Seeger, ZL | 1 |
| Izgorodina, EI | 1 |
| Hue, S | 1 |
| Beldi-Ferchiou, A | 1 |
| Bendib, I | 1 |
| Surenaud, M | 1 |
| Fourati, S | 1 |
| Frapard, T | 1 |
| Rivoal, S | 1 |
| Razazi, K | 1 |
| Carteaux, G | 1 |
| Delfau-Larue, MH | 1 |
| Mekontso-Dessap, A | 1 |
| Audureau, E | 1 |
| de Prost, N | 1 |
| Gao, SS | 1 |
| Duangthip, D | 1 |
| Lo, ECM | 1 |
| Chu, CH | 1 |
| Roberts, W | 1 |
| Rosenheck, RA | 1 |
| Miyake, T | 1 |
| Kimoto, E | 1 |
| Luo, L | 1 |
| Mathialagan, S | 1 |
| Horlbogen, LM | 1 |
| Ramanathan, R | 1 |
| Wood, LS | 1 |
| Johnson, JG | 1 |
| Le, VH | 1 |
| Vourvahis, M | 1 |
| Rodrigues, AD | 1 |
| Muto, C | 1 |
| Furihata, K | 1 |
| Sugiyama, Y | 1 |
| Kusuhara, H | 1 |
| Gong, Q | 1 |
| Song, W | 1 |
| Sun, B | 1 |
| Cao, P | 1 |
| Gu, S | 1 |
| Sun, X | 1 |
| Zhou, G | 1 |
| Toma, C | 1 |
| Khandhar, S | 1 |
| Zalewski, AM | 1 |
| D'Auria, SJ | 1 |
| Tu, TM | 1 |
| Jaber, WA | 1 |
| Cho, J | 2 |
| Suwandaratne, NS | 1 |
| Razek, S | 1 |
| Choi, YH | 1 |
| Piper, LFJ | 1 |
| Watson, DF | 1 |
| Banerjee, S | 1 |
| Xie, S | 1 |
| Lindsay, AP | 1 |
| Bates, FS | 1 |
| Lodge, TP | 1 |
| Hao, Y | 1 |
| Chapovetsky, A | 1 |
| Liu, JJ | 1 |
| Welborn, M | 1 |
| Luna, JM | 1 |
| Do, T | 1 |
| Haiges, R | 1 |
| Miller Iii, TF | 1 |
| Marinescu, SC | 1 |
| Lopez, SA | 1 |
| Compter, I | 1 |
| Eekers, DBP | 1 |
| Hoeben, A | 1 |
| Rouschop, KMA | 1 |
| Reymen, B | 1 |
| Ackermans, L | 1 |
| Beckervordersantforth, J | 1 |
| Bauer, NJC | 1 |
| Anten, MM | 1 |
| Wesseling, P | 1 |
| Postma, AA | 1 |
| De Ruysscher, D | 1 |
| Lambin, P | 1 |
| Qiang, L | 1 |
| Yang, S | 1 |
| Cui, YH | 1 |
| He, YY | 1 |
| Kumar, SK | 1 |
| Jacobus, SJ | 1 |
| Cohen, AD | 1 |
| Weiss, M | 1 |
| Callander, N | 1 |
| Singh, AK | 1 |
| Parker, TL | 1 |
| Menter, A | 1 |
| Parsons, B | 1 |
| Kumar, P | 1 |
| Kapoor, P | 1 |
| Rosenberg, A | 1 |
| Zonder, JA | 1 |
| Faber, E | 1 |
| Lonial, S | 1 |
| Anderson, KC | 1 |
| Richardson, PG | 1 |
| Orlowski, RZ | 1 |
| Wagner, LI | 1 |
| Rajkumar, SV | 1 |
| Li, G | 1 |
| Hou, G | 1 |
| Cui, J | 1 |
| Xie, H | 1 |
| Sun, Z | 1 |
| Fang, Z | 1 |
| Dunstand-Guzmán, E | 1 |
| Hallal-Calleros, C | 1 |
| Hernández-Velázquez, VM | 1 |
| Canales-Vargas, EJ | 1 |
| Domínguez-Roldan, R | 1 |
| Pedernera, M | 1 |
| Peña-Chora, G | 1 |
| Flores-Pérez, I | 1 |
| Kim, MJ | 1 |
| Han, C | 1 |
| White, K | 1 |
| Park, HJ | 1 |
| Ding, D | 1 |
| Boyd, K | 1 |
| Rothenberger, C | 1 |
| Bose, U | 1 |
| Carmichael, P | 1 |
| Linser, PJ | 1 |
| Tanokura, M | 1 |
| Salvi, R | 1 |
| Someya, S | 1 |
| Samuni, A | 1 |
| Goldstein, S | 1 |
| Divya, KP | 1 |
| Dharuman, V | 1 |
| Feng, J | 2 |
| Qian, Y | 1 |
| Cheng, Q | 1 |
| Ma, H | 1 |
| Ren, X | 1 |
| Wei, Q | 1 |
| Pan, W | 1 |
| Guo, J | 1 |
| Situ, B | 1 |
| An, T | 1 |
| Zheng, L | 1 |
| Augusto, S | 1 |
| Ratola, N | 1 |
| Tarín-Carrasco, P | 1 |
| Jiménez-Guerrero, P | 1 |
| Turco, M | 1 |
| Schuhmacher, M | 1 |
| Costa, S | 1 |
| Teixeira, JP | 1 |
| Costa, C | 1 |
| Syed, A | 1 |
| Marraiki, N | 1 |
| Al-Rashed, S | 1 |
| Elgorban, AM | 1 |
| Yassin, MT | 1 |
| Chankhanittha, T | 1 |
| Nanan, S | 1 |
| Sorokina, KN | 1 |
| Samoylova, YV | 1 |
| Gromov, NV | 1 |
| Ogorodnikova, OL | 1 |
| Parmon, VN | 1 |
| Ye, J | 1 |
| Liao, W | 1 |
| Zhang, P | 1 |
| Nabi, M | 1 |
| Cai, Y | 2 |
| Li, F | 1 |
| Alsbou, EM | 1 |
| Omari, KW | 1 |
| Adeosun, WA | 1 |
| Asiri, AM | 1 |
| Marwani, HM | 1 |
| Barral, M | 1 |
| Jemal-Turki, A | 1 |
| Beuvon, F | 1 |
| Soyer, P | 1 |
| Camparo, P | 1 |
| Cornud, F | 1 |
| Atwater, BD | 1 |
| Jones, WS | 1 |
| Loring, Z | 1 |
| Friedman, DJ | 1 |
| Namburath, M | 1 |
| Papirio, S | 1 |
| Moscariello, C | 1 |
| Di Costanzo, N | 1 |
| Pirozzi, F | 1 |
| Alappat, BJ | 1 |
| Sreekrishnan, TR | 1 |
| Volpin, F | 1 |
| Woo, YC | 1 |
| Kim, H | 1 |
| Freguia, S | 1 |
| Jeong, N | 1 |
| Choi, JS | 1 |
| Phuntsho, S | 1 |
| Shon, HK | 1 |
| Domínguez-Zambrano, E | 1 |
| Pedraza-Chaverri, J | 1 |
| López-Santos, AL | 1 |
| Medina-Campos, ON | 1 |
| Cruz-Rivera, C | 1 |
| Bueno-Hernández, F | 1 |
| Espinosa-Cuevas, A | 1 |
| Bulavaitė, A | 1 |
| Dalgediene, I | 1 |
| Michailoviene, V | 1 |
| Pleckaityte, M | 1 |
| Sauerbier, P | 1 |
| Köhler, R | 1 |
| Renner, G | 1 |
| Militz, H | 1 |
| Toriyama, K | 1 |
| Suzuki, T | 1 |
| Higashiura, R | 1 |
| Maeda, N | 1 |
| Ohashi, Y | 1 |
| Zueva, LB | 1 |
| Etienne, M | 1 |
| Van Elslande, H | 1 |
| Choplin-Renard, J | 1 |
| Pestel-Caron, M | 1 |
| Caron, F | 1 |
| Ranjan, A | 1 |
| Murthy, SI | 1 |
| Rathi, VM | 1 |
| Sangwan, VS | 1 |
| Pezzilli, R | 1 |
| Domínguez Jiménez, JL | 1 |
| Bernal Blanco, E | 1 |
| Marín Moreno, MA | 1 |
| Puente Gutiérrez, JJ | 1 |
| Carrascosa, MF | 1 |
| Lucena, MI | 1 |
| Andrade, RJ | 2 |
| Caviedes, JR | 1 |
| Lavín, AC | 1 |
| Mones, JC | 1 |
| Rivero, AP | 1 |
| Serrano, VB | 1 |
| Regalado, NG | 1 |
| Martin, G | 1 |
| Antony, SJ | 1 |
| Khan, MA | 1 |
| Xiao, Y | 1 |
| Xu, N | 2 |
| Bai, C | 1 |
| Xiu, Q | 1 |
| Mei, C | 1 |
| Zheng, Q | 1 |
| Figueira-Coelho, J | 1 |
| Pereira, O | 1 |
| Picado, B | 1 |
| Mendonça, P | 1 |
| Neves-Costa, J | 1 |
| Neta, J | 1 |
| Rafat, C | 1 |
| Vimont, S | 1 |
| Ancel, PY | 1 |
| Xu-Dubois, YC | 1 |
| Mesnard, L | 1 |
| Ouali, N | 1 |
| Denis, M | 1 |
| Vandewalle, A | 1 |
| Rondeau, E | 1 |
| Hertig, A | 1 |
| Titos-Arcos, JC | 1 |
| Hallal, H | 1 |
| Robles, M | 1 |
| Kim, NY | 1 |
| Park, JS | 1 |
| Lee, KJ | 1 |
| Yun, HK | 1 |
| Kim, JS | 1 |
| Treszezamsky, AD | 1 |
| Feldman, D | 1 |
| Sarabanchong, VO | 1 |
| Ficko, C | 1 |
| Mellon, G | 1 |
| Andriamanantena, D | 1 |
| Merens, A | 1 |
| Rapp, C | 1 |
| Chuang, TY | 1 |
| Lin, CJ | 1 |
| Lee, SW | 1 |
| Chuang, CP | 1 |
| Jong, YS | 1 |
| Chen, WJ | 1 |
| Hsueh, PR | 1 |
| Nicolau, DP | 2 |
| Sutherland, C | 1 |
| Winget, D | 1 |
| Baughman, RP | 1 |
| Okovityĭ, SV | 1 |
| Muzykin, MI | 1 |
| Iordanishvili, AK | 1 |
| Pessey, JJ | 2 |
| Bru, JP | 2 |
| Zuck, P | 2 |
| Weiss, LR | 1 |
| Jones, JW | 1 |
| Kiefe, CI | 1 |
| Iakovlev, SV | 1 |
| Iakovlev, VP | 1 |
| Kriukov, AI | 2 |
| Sedinkin, AA | 2 |
| Aleksanian, TA | 1 |
| Kiesslich, R | 1 |
| Will, D | 1 |
| Hahn, M | 1 |
| Nafe, B | 1 |
| Genitsariotis, R | 1 |
| Mäurer, M | 1 |
| Jung, M | 1 |
| Liang, D | 1 |
| Miao, J | 1 |
| Qiu, D | 1 |
| Wen, C | 1 |
| Amsden, GW | 1 |
| Baird, IM | 1 |
| Simon, S | 1 |
| Treadway, G | 1 |
| Odagiri, S | 2 |
| Watanuki, Y | 1 |
| Takahashi, H | 1 |
| Shimada, J | 1 |
| Gerasimov, KV | 1 |
| Schwalm, JD | 1 |
| Lee, CH | 1 |
| Kanemitsu, N | 1 |
| Hayashi, I | 1 |
| Satoh, N | 1 |
| Hayakawa, T | 1 |
| Mitsuya, H | 1 |
| Hayase, Y | 1 |
| Hiramoto, K | 1 |
| Kojima, M | 1 |
| Gonzales, R | 1 |
| Matsuzaki, K | 1 |
| Yoshimori, K | 1 |
| Shikano, M | 1 |
| Watabe, E | 1 |
| Sato, Y | 1 |
| Hasegawa, M | 1 |
| Kobayashi, I | 1 |
| Yamanaka, N | 1 |
| Airey, K | 1 |
| Koller, E | 1 |
| Roland, PS | 1 |
| Kreisler, LS | 1 |
| Reese, B | 1 |
| Anon, JB | 2 |
| Lanier, B | 1 |
| Conroy, PJ | 1 |
| Wall, GM | 1 |
| Dupre, SJ | 1 |
| Potts, S | 1 |
| Hogg, G | 1 |
| Stroman, DW | 1 |
| McLean, C | 1 |
| Leophonte, P | 1 |
| Veyssier, P | 2 |
| Yamaguchi, H | 1 |
| Uchino, K | 1 |
| Yokoyama, H | 1 |
| Matsumoto, T | 1 |
| Jareoncharsri, P | 1 |
| Bunnag, C | 1 |
| Fooanant, S | 1 |
| Tunsuriyawong, P | 1 |
| Voraprayoon, S | 1 |
| Srifuengfung, S | 1 |
| Dhiraputra, C | 1 |
| Drury, NE | 1 |
| Dyer, JP | 1 |
| Breitenfeldt, N | 1 |
| Adamson, AS | 1 |
| Harrison, GS | 1 |
| Taylor, E | 1 |
| Berjis, A | 1 |
| Bosch, T | 1 |
| Hoehne, F | 1 |
| Ozaeta, M | 1 |
| Brumpt, I | 1 |
| Onek, T | 1 |
| Erkan, N | 1 |
| Zeytunlu, M | 1 |
| Sağol, O | 1 |
| Coker, C | 1 |
| Coker, A | 1 |
| Henry, DC | 1 |
| Kapral, D | 1 |
| Busman, TA | 1 |
| Paris, MM | 1 |
| Corral de la Calle, M | 1 |
| Martín Díaz, MA | 1 |
| Flores, CR | 1 |
| Vidaurrazaga, C | 1 |
| Gehanno, P | 1 |
| Serrano, E | 1 |
| Ma, ES | 1 |
| Wong, CL | 1 |
| Lai, KT | 1 |
| Chan, EC | 1 |
| Yam, WC | 1 |
| Chan, AC | 1 |
| Murray, JJ | 1 |
| Emparanza, P | 1 |
| Lesinskas, E | 1 |
| Tawadrous, M | 1 |
| Breen, JD | 1 |
| Marple, BF | 2 |
| Gyang, A | 1 |
| Kalu, E | 1 |
| Fakokunde, A | 1 |
| Whitlow, B | 1 |
| Cazzola, M | 1 |
| Matera, MG | 1 |
| Donnarumma, G | 1 |
| Tufano, MA | 1 |
| Sanduzzi, A | 1 |
| Marchetti, F | 1 |
| Blasi, F | 1 |
| Stroud, LF | 1 |
| Mamdami, MM | 1 |
| Kopp, A | 1 |
| Bell, CM | 1 |
| Poole, M | 1 |
| Anon, J | 1 |
| Paglia, M | 2 |
| Xiang, J | 2 |
| Khashab, M | 5 |
| Kahn, J | 1 |
| Keating, KN | 1 |
| Friedman, HS | 1 |
| Perfetto, EM | 1 |
| Martinez, FJ | 1 |
| Hadley, JA | 1 |
| Zamir, D | 1 |
| Weiler, Z | 1 |
| Kogan, E | 1 |
| Ben-Valid, E | 1 |
| Hay, E | 1 |
| Reitblat, T | 1 |
| Polishchuk, I | 1 |
| Rival, G | 1 |
| Garot, D | 1 |
| Mercier, E | 1 |
| Narciso, B | 1 |
| Legras, A | 1 |
| Perrotin, D | 1 |
| Dequin, PF | 1 |
| Rafalsky, V | 1 |
| Andreeva, I | 1 |
| Rjabkova, E | 1 |
| Soriano, A | 1 |
| García, S | 1 |
| Bori, G | 1 |
| Almela, M | 1 |
| Gallart, X | 1 |
| Macule, F | 1 |
| Sierra, J | 1 |
| Martínez, JA | 1 |
| Suso, S | 1 |
| Mensa, J | 1 |
| Leibovici, L | 2 |
| Paul, M | 2 |
| Cullen, M | 1 |
| Bucaneve, G | 1 |
| Gafter-Gvili, A | 1 |
| Fraser, A | 1 |
| Kern, WV | 3 |
| Borlenghi, E | 1 |
| Cattaneo, C | 1 |
| Capucci, MA | 1 |
| Pan, A | 1 |
| Quaresmini, G | 1 |
| Franco, F | 1 |
| Grazioli, L | 1 |
| Carosi, GP | 1 |
| Rossi, G | 1 |
| Arguedas, A | 1 |
| Dagan, R | 2 |
| Pichichero, M | 1 |
| Leibovitz, E | 2 |
| Blumer, J | 1 |
| McNeeley, DF | 2 |
| Melkote, R | 1 |
| Noel, GJ | 2 |
| Ambrose, PG | 1 |
| Jones, RN | 1 |
| Kahn, JB | 5 |
| Ambruzs, M | 1 |
| Griffith, ME | 1 |
| Moon, JE | 1 |
| Johnson, EN | 1 |
| Clark, KP | 1 |
| Hawley, JS | 1 |
| Hospenthal, DR | 1 |
| Murray, CK | 1 |
| Yamamoto, A | 1 |
| Konishi, I | 1 |
| Kumata, M | 1 |
| Klausner, HA | 1 |
| Brown, P | 1 |
| Peterson, J | 3 |
| Kaul, S | 3 |
| Fisher, AC | 2 |
| Soussy, CJ | 1 |
| Lascols, C | 1 |
| Dib-Smahi, C | 1 |
| Davies, TA | 1 |
| Bush, K | 1 |
| Fisher, A | 1 |
| Roberts, CS | 1 |
| de Caprariis, PJ | 1 |
| Reisman, A | 1 |
| Tazi, A | 1 |
| Gueudet, T | 1 |
| Varon, E | 1 |
| Gilly, L | 1 |
| Trieu-Cuot, P | 1 |
| Poyart, C | 1 |
| Hara, S | 1 |
| Nakasu, H | 1 |
| Saito, M | 1 |
| Seo, T | 1 |
| Matsubara, Y | 1 |
| Tomizawa, I | 1 |
| Takizawa, Y | 1 |
| Ito, K | 2 |
| Konishi, K | 1 |
| Matsunaga, M | 1 |
| Yanagishita, T | 1 |
| Kosugi, M | 1 |
| Landau, Z | 1 |
| Agmon, NL | 1 |
| Argas, D | 1 |
| Arcavi, L | 1 |
| Simon, D | 1 |
| Miskin, A | 1 |
| Hooton, TM | 3 |
| Winter, C | 2 |
| Tiu, F | 1 |
| Stamm, WE | 3 |
| Eriksson, S | 1 |
| Granström, L | 1 |
| Okuyama, A | 1 |
| Miki, T | 1 |
| Kokado, Y | 1 |
| Fujioka, H | 1 |
| Kuroda, H | 1 |
| Takatera, H | 1 |
| Yasunaga, Y | 1 |
| Kishimoto, T | 1 |
| Yamada, R | 1 |
| Oda, M | 1 |
| Regev, G | 1 |
| Mouallem, M | 1 |
| Markus, A | 1 |
| Andriof, E | 1 |
| Hay, B | 1 |
| Kern, P | 1 |
| Marre, R | 1 |
| Arnold, R | 1 |
| Pfau, A | 1 |
| Sacks, TG | 1 |
| Halstensen, A | 2 |
| Voltersvik, P | 2 |
| Gossius, G | 1 |
| Digranes, A | 2 |
| Peterson, LE | 3 |
| Rolstad, T | 3 |
| Solberg, CO | 2 |
| Noguerado, A | 1 |
| Garcia-Polo, I | 1 |
| Isasia, T | 1 |
| Jimenez, ML | 1 |
| Bermudez, P | 1 |
| Pita, J | 1 |
| Gabriel, R | 1 |
| Frosco, MB | 1 |
| Melton, JL | 1 |
| Stewart, FP | 1 |
| Kulwich, BA | 1 |
| Licata, L | 1 |
| Barrett, JF | 1 |
| Savel'eva, GM | 1 |
| Evseev, AA | 1 |
| Denisova, EN | 1 |
| Pytel', IuA | 1 |
| Volkova, VS | 1 |
| Lobzin, IuV | 1 |
| Spanik, S | 1 |
| Trupl, J | 1 |
| Kunova, A | 1 |
| Botek, R | 1 |
| Sorkovska, D | 1 |
| Grey, E | 1 |
| Studena, M | 1 |
| Lacka, J | 1 |
| Oravcova, E | 1 |
| Krchnakova, A | 1 |
| Rusnakova, V | 1 |
| Svec, J | 1 |
| Krupova, I | 1 |
| Grausova, S | 1 |
| Stopkova, K | 1 |
| Koren, P | 1 |
| Krcmery, V | 1 |
| Nie, L | 1 |
| Tessier, PR | 1 |
| Kourea, HP | 1 |
| Nightingale, CH | 1 |
| Sydnor, TA | 1 |
| Kopp, EJ | 1 |
| Anthony, KE | 1 |
| LoCoco, JM | 1 |
| Kim, SS | 2 |
| Fowler, CL | 3 |
| Richard, GA | 1 |
| Klimberg, IN | 1 |
| Callery-D'Amico, S | 1 |
| DeAbate, CA | 2 |
| Henry, D | 2 |
| Bensch, G | 1 |
| Jubran, A | 1 |
| Chodosh, S | 2 |
| Harper, L | 1 |
| Tipping, D | 1 |
| Talbot, GH | 2 |
| Ellison, W | 1 |
| Sullivan, J | 1 |
| Mansfield, DL | 1 |
| Magner, DJ | 1 |
| Dorr, MB | 1 |
| Adelglass, J | 1 |
| McElvaine, P | 1 |
| LoCocco, J | 1 |
| Campbell, T | 1 |
| McCarty, JM | 1 |
| Richard, G | 1 |
| Huck, W | 1 |
| Tucker, RM | 1 |
| Tosiello, RL | 1 |
| Shan, M | 1 |
| Heyd, A | 1 |
| Echols, RM | 1 |
| Goldblatt, EL | 2 |
| Dohar, J | 1 |
| Nozza, RJ | 1 |
| Nielsen, RW | 1 |
| Goldberg, T | 1 |
| Sidman, JD | 1 |
| Seidlin, M | 1 |
| Lasko, B | 1 |
| Lau, CY | 1 |
| Saint-Pierre, C | 1 |
| Reddington, JL | 1 |
| Martel, A | 1 |
| Anstey, RJ | 1 |
| Koga, H | 1 |
| Aoyagi, K | 1 |
| Yoshimura, R | 1 |
| Kimura, Y | 2 |
| Iida, M | 1 |
| Fujishima, M | 1 |
| Baril, L | 1 |
| Maisonobe, T | 1 |
| Jasson-Molinier, M | 1 |
| Haroche, J | 1 |
| Bricaire, F | 1 |
| Caumes, E | 1 |
| Tsang, KW | 1 |
| Chan, WM | 1 |
| Ho, PL | 1 |
| Chan, K | 1 |
| Lam, WK | 1 |
| Ip, MS | 1 |
| Koyama, Y | 1 |
| Mikami, O | 1 |
| Matsuda, T | 1 |
| Murota, T | 1 |
| Ohara, T | 1 |
| Kawamura, H | 1 |
| Amazutsumi, K | 1 |
| Uchida, J | 1 |
| Harada, T | 1 |
| Asvanich, K | 1 |
| Fugpholngam, V | 1 |
| Srimuang, S | 1 |
| Tanphaichitra, D | 1 |
| Langeland, N | 1 |
| Revelo, MP | 1 |
| Paueksakon, P | 1 |
| Goral, S | 1 |
| Helderman, H | 1 |
| Fogo, AB | 1 |
| Klein, JO | 2 |
| McCracken, GH | 1 |
| Scheen, AJ | 1 |
| Kawamura, M | 1 |
| Owada, M | 1 |
| Fujiwara, T | 1 |
| Maesawa, C | 1 |
| Hiramori, K | 1 |
| Scotton, PG | 1 |
| Pea, F | 1 |
| Giobbia, M | 1 |
| Baraldo, M | 1 |
| Vaglia, A | 1 |
| Furlanut, M | 1 |
| Budanov, SV | 1 |
| Vasil'ev, AN | 1 |
| Smirnova, LB | 1 |
| Karim, A | 1 |
| Ahmed, S | 1 |
| Rossoff, LJ | 1 |
| Siddiqui, RK | 1 |
| Steinberg, HN | 1 |
| Masterton, RG | 1 |
| Burley, CJ | 1 |
| Soares-Weiser, K | 1 |
| Brezis, M | 1 |
| Yamada, Y | 1 |
| Mennecier, D | 1 |
| Thiolet, C | 1 |
| Bredin, C | 1 |
| Potier, V | 1 |
| Vergeau, B | 1 |
| Farret, O | 1 |
| Pedrós, A | 1 |
| Emilio Gómez, J | 1 |
| Angel Navarro, L | 1 |
| Tomás, A | 1 |
| Naber, KG | 1 |
| Thyroff-Friesinger, U | 1 |
| Kumamoto, Y | 2 |
| Hirose, T | 1 |
| Nishimura, M | 1 |
| Aoki, M | 1 |
| Tsukamoto, T | 1 |
| Miyake, M | 1 |
| Yanase, M | 1 |
| Miyao, N | 1 |
| Akagashi, K | 1 |
| Yokoo, A | 1 |
| Soper, DE | 1 |
| Brockwell, NJ | 1 |
| Dalton, HP | 1 |
| Saito, I | 1 |
| Suzuki, A | 1 |
| Saiko, Y | 1 |
| Yokozawa, M | 1 |
| Ono, K | 1 |
| Miyata, K | 1 |
| Miyamura, R | 1 |
| Hamaya, O | 1 |
| Kaneko, K | 1 |
| Yamamoto, T | 2 |
| Azoulay-Dupuis, E | 1 |
| Bedos, JP | 1 |
| Vallée, E | 1 |
| Pocidalo, JJ | 1 |
| Kampf, D | 1 |
| Borner, K | 1 |
| Hain, H | 1 |
| Conrad, W | 1 |
| Watanabe, A | 1 |
| Blum, A | 1 |
| Johnson, C | 2 |
| Kuwamura, L | 1 |
| Rogers, ME | 1 |
| Roberts, PL | 2 |
| Wendel, GD | 1 |
| Cox, SM | 1 |
| Bawdon, RE | 1 |
| Theriot, SK | 1 |
| Heard, MC | 1 |
| Nobles, BJ | 1 |
| De Simone, C | 1 |
| Di Fabio, S | 1 |
| Moretti, S | 1 |
| Tzantzoglou, S | 1 |
| Trinchieri, V | 1 |
| Gargiulo, M | 1 |
| Weidner, W | 3 |
| Garbe, C | 3 |
| Weissbach, L | 2 |
| Harbrecht, J | 2 |
| Kleinschmidt, K | 2 |
| Schiefer, HG | 3 |
| Friedrich, HJ | 2 |
| Dopff, C | 1 |
| Mertes, PM | 1 |
| Nace, L | 1 |
| Gerard, A | 1 |
| Voiriot, P | 1 |
| Preiss, MA | 1 |
| May, T | 1 |
| Canton, P | 1 |
| Dureux, JB | 1 |
| Davis, GJ | 1 |
| McKenzie, BE | 1 |
| Latham, RH | 1 |
| Wong, ES | 1 |
| Yamaguchi, K | 1 |
| Kawaguchi, K | 1 |
| Muraki, N | 1 |
| Chen, RM | 1 |
| Kakusaka, I | 1 |
| Kuriyama, T | 1 |
| Kanno, H | 1 |
| Kikuchi, N | 1 |
| Suzuki, K | 1 |
| Yamagishi, F | 1 |
| Watanabe, S | 1 |
| Egede, F | 1 |
| Kristensen, I | 1 |
| Sakashita, S | 1 |
| Kumagai, A | 1 |
| Yamazaki, H | 1 |
| Nantani, M | 1 |
| Sakakibara, N | 1 |
| Tsubo, S | 1 |
| Togashi, M | 1 |
| Maru, A | 1 |
| Koyanagi, T | 1 |
| Hasçelik, G | 1 |
| Lenarz, T | 2 |
| Miyata, M | 1 |
| Inagaki, N | 1 |
| Inada, F | 1 |
| Yachiku, S | 1 |
| Okamura, K | 1 |
| Osanai, H | 1 |
| Mizunaga, M | 1 |
| Morikawa, M | 1 |
| Block, JM | 1 |
| Walstad, RA | 1 |
| Bjertnaes, A | 1 |
| Hafstad, PE | 1 |
| Holte, M | 1 |
| Ottemo, I | 1 |
| Svarva, PL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prophylaxis With Single Versus Five Dose of Antibiotic Therapy as Treatment of Patients With Gangrenous Acute Appendicitis (Randomized, Controlled Clinical Trial)[NCT01115153] | 150 participants (Actual) | Interventional | 2007-12-31 | Completed | |||
| An Open-Label Study of Levofloxacin to Evaluate Bacteriologic Outcome in the Treatment of Children Who Are at Risk for Acute Otitis Media That is Difficult to Treat[NCT00044473] | Phase 3 | 206 participants (Actual) | Interventional | 2002-11-30 | Completed | ||
| An Open-label, Multi-center, Non-comparative Sinus Puncture Study of 750 mg, Short-course Levofloxacin in the Treatment of Acute Maxillary Sinusitis[NCT00236652] | Phase 3 | 18 participants (Actual) | Interventional | 2003-11-30 | Completed | ||
| [NCT00042718] | Phase 3 | 659 participants (Actual) | Interventional | 2001-11-30 | Completed | ||
| A Multicenter, Double-blind, Randomized Study to Compare the Efficacy and Safety of Levofloxacin 750 mg Once Daily for Five Days Versus Ciprofloxacin Twice Daily for Ten Days in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis[NCT00210886] | Phase 3 | 1,109 participants (Actual) | Interventional | 2004-10-31 | Completed | ||
| Controlling Antimicrobial Use Through Reducing Unnecessary Treatment of Catheter Associated Urinary Tract Infections (CARCUTI)[NCT02650518] | Phase 2/Phase 3 | 500 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
| Randomized Study of Conservative Versus Surgical Treatment of Appendicitis; Analyses of Result and Economics[NCT00469430] | Phase 2 | 360 participants (Actual) | Interventional | 2006-05-31 | Completed | ||
| Non Operative Treatment for Acute Appendicitis: Study on Efficacy and Safety of Antibiotic Treatment (Amoxicillin and Clavulanic Acid) in Patients With Right Sided Lower Abdominal Pain[NCT01096927] | Phase 4 | 160 participants (Actual) | Interventional | 2010-01-31 | Completed | ||
| A Prospective Non-randomized Controlled, Multicenter, Multidisciplinary Trial Comparing Appendectomy and Conservative Treatment for Patients With Uncomplicated Acute Appendicitis (the ACTUAA STUDY).[NCT03080103] | 300 participants (Actual) | Observational | 2017-06-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 reviews available for ofloxacin and Acute Disease
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli | 2021 |
[Update on levofloxacin in the management of acute sinusitis with risk of complications].
Topics: Abscess; Acute Disease; Anti-Infective Agents; Cellulitis; Clinical Trials as Topic; Disease Progres | 2002 |
[Levofloxacin in the treatment of respiratory infections].
Topics: Acute Disease; Anti-Infective Agents; Bronchitis, Chronic; Clinical Trials as Topic; Drug Resistance | 2002 |
[Levofloxacine for the treatment of pneumococcal pneumonia: results of a meta-analysis].
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Humans; | 2003 |
Acute exacerbation of chronic bronchitis: expanding short-course therapy.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Azithromycin; Bronchitis; Clinical Trials as Topic; Conf | 2005 |
Quinolones for uncomplicated acute cystitis in women.
Topics: Acute Disease; Adult; Anti-Infective Agents, Urinary; Ciprofloxacin; Cystitis; Female; Fluoroquinolo | 2006 |
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Topics: Acute Disease; Antibiotic Prophylaxis; Antineoplastic Agents; Bone Marrow Transplantation; Ciproflox | 2006 |
Acute cholecystitis caused by Campylobacter jejuni.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Infective Agents; Campylobacter Infections; Campylobact | 1995 |
In vitro and in vivo antimicrobial activity of topical ofloxacin and other ototopical agents.
Topics: Acute Disease; Anti-Infective Agents; Anti-Infective Agents, Local; Chronic Disease; Clinical Trials | 2001 |
The use of topical ofloxacin for otic diseases in infants and children. Summary and conclusions.
Topics: Acute Disease; Anti-Infective Agents; Anti-Infective Agents, Local; Chronic Disease; Humans; Middle | 2001 |
[The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
Topics: Acute Disease; Animals; Anti-Infective Agents; Bronchitis; Chronic Disease; Community-Acquired Infec | 2001 |
Evidence based case report. Antibiotic treatment for spontaneous bacterial peritonitis.
Topics: Acute Disease; Anti-Bacterial Agents; Cefotaxime; Evidence-Based Medicine; Female; Gram-Negative Bac | 2002 |
Use of quinolones for the treatment of acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Anti-Infective Agents; Bronchitis; Chronic Disease; Ciprofloxacin; Fluoroquinolones; | 1991 |
Toxicologic evaluation of ofloxacin.
Topics: Abnormalities, Drug-Induced; Acute Disease; Animals; Chronic Disease; Dogs; Ofloxacin; Rats | 1989 |
61 trials available for ofloxacin and Acute Disease
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acryli | 2021 |
[Zoflox, an antibacterial drug, in treatment of infectious pathologic processes in the lower respiratory tract complicating acute respiratory viral infection in elderly patients].
Topics: Acute Disease; Aged; Ambulatory Care; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Femal | 2012 |
Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacteria | 2009 |
A phase II study of antofloxacin hydrochloride, a novel fluoroquinolone, for the treatment of acute bacterial infections.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Bronchitis, Chronic; Demography; Double-Blind Met | 2010 |
Bronchopulmonary pharmacokinetic and pharmacodynamic profiles of levofloxacin 750 mg once daily in adults undergoing treatment for acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; | 2012 |
Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Bronchit | 2002 |
[Ceftriaxone versus Levofloxacin for antibiotic therapy in patients with acute cholangitis].
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bact | 2003 |
[Multicenter evaluation on the efficacy and safety of sparfloxacin in the treatment of acute bacterial infections].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Drug Administra | 2002 |
Efficacy and safety of azithromycin vs levofloxacin in the outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial In | 2003 |
[Efficacy of the drug tavanik (levofloxacin) in acute and maxillary sinusitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Drug Administration Schedule; Female; | 2003 |
Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes.
Topics: Acute Disease; Administration, Topical; Anti-Infective Agents; Anti-Inflammatory Agents; Child; Chil | 2004 |
An open label, randomized comparative study of levofloxacin and amoxicillin/clavulanic acid in the treatment of purulent sinusitis in adult Thai patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infectiv | 2004 |
The efficacy of postoperative oral antibiotics in appendicitis: a randomized prospective double-blinded study.
Topics: Abdominal Abscess; Acute Disease; Administration, Oral; Adolescent; Adult; Ambulatory Care; Amoxicil | 2004 |
Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Cefdinir; Cephalosporins; Double-Blind Method; Fe | 2004 |
[Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
Topics: Acute Disease; Adolescent; Adult; Africa, Southern; Aged; Bacterial Infections; Female; France; Haem | 2005 |
Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacte | 2005 |
Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Area Under Curve; Bronchitis; Disease Progression; Femal | 2005 |
A trial of high-dose, short-course levofloxacin for the treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Double-Blind Me | 2006 |
Single-dose quinolone treatment in acute gastroenteritis.
Topics: Acute Disease; Adult; Analysis of Variance; Anti-Bacterial Agents; Diarrhea; Female; Gastroenteritis | 2006 |
An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Child, Preschool; Exudates and | 2006 |
Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Catheters, Indwelling; Dose-Response Relationship, Drug | 2007 |
Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
Topics: Acute Disease; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromy | 2007 |
A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Double-Blind Method; Drug Administ | 2007 |
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Ciprof | 2007 |
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Do | 2008 |
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Do | 2008 |
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Do | 2008 |
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Ciprofloxacin; Do | 2008 |
[Comparison of clinical efficacy of ofloxacin COFLX: DL-8280) and pipemidic acid (PPA) in acute infectious diarrhea by a double-blind method. The Japan Research Committee of Ofloxacin, Research Group for Acute Infectious Diarrhea].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Campylobacter I | 1984 |
Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women.
Topics: Acute Disease; Adult; Amoxicillin; Anti-Infective Agents; Cefadroxil; Confidence Intervals; Costs an | 1995 |
Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Appendicitis; Cefotaxime; Female; Humans; Male; Middle Aged; | 1995 |
Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Appendicitis; Cefotaxime; Female; Humans; Male; Middle Aged; | 1995 |
Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Appendicitis; Cefotaxime; Female; Humans; Male; Middle Aged; | 1995 |
Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Appendicitis; Cefotaxime; Female; Humans; Male; Middle Aged; | 1995 |
Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Appendicitis; Cefotaxime; Female; Humans; Male; Middle Aged; | 1995 |
Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Appendicitis; Cefotaxime; Female; Humans; Male; Middle Aged; | 1995 |
Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Appendicitis; Cefotaxime; Female; Humans; Male; Middle Aged; | 1995 |
Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Appendicitis; Cefotaxime; Female; Humans; Male; Middle Aged; | 1995 |
Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Appendicitis; Cefotaxime; Female; Humans; Male; Middle Aged; | 1995 |
[Clinical evaluation on ofloxacin administered once daily in the treatment of acute uncomplicated cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Cystitis; Drug Administration Schedule; Female; Humans; Japa | 1994 |
A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Bone Marrow Transplantation; Cyclospo | 1994 |
Single dose quinolone treatment in acute uncomplicated urinary tract infection in women.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Gram-Negative Bacterial Infect | 1993 |
Double-blind comparison of ofloxacin for 3 days and placebo in acute bacterial enteritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Double-Blind Method; Gastroenteritis; | 1995 |
Early single dose therapy with ofloxacin for empirical treatment of acute gastroenteritis: a randomised, placebo-controlled double-blind clinical trial.
Topics: Acute Disease; Adult; Anti-Infective Agents; Diarrhea; Double-Blind Method; Feces; Female; Follow-Up | 1995 |
[Comparative evaluation of the effectiveness of ofloxacin in comprehensive treatment of acute inflammatory diseases of the uterus and uterine appendages].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents | 1996 |
[Comprehensive treatment with ofloxacin in pyo-inflammatory urologic diseases].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Infective Agents, Urinary; Anti-Inflammatory | 1996 |
[An attempt to use ofloxacin in the treatment of acute intestinal infections].
Topics: Acute Disease; Anti-Infective Agents; Chlamydia Infections; Drug Resistance, Microbial; Dysentery, B | 1996 |
Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bacterial Infections; Exudates and Transudates; Female; | 1998 |
Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Fem | 1998 |
Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chlamy | 1998 |
Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Community-Acquired Infections; Female; Fluo | 1998 |
Comparison of the effectiveness of levofloxacin and amoxicillin-clavulanate for the treatment of acute sinusitis in adults.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Am | 1999 |
A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Infective Agents, Urinary | 1999 |
Topical ofloxacin versus systemic amoxicillin/clavulanate in purulent otorrhea in children with tympanostomy tubes.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Amoxicillin-Potassium Clavulanate Comb | 1998 |
Efficacy and safety of oral levofloxacin compared with clarithromycin in the treatment of acute sinusitis in adults: a multicentre, double-blind, randomized study. The Canadian Sinusitis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agen | 1998 |
A comparative study on the efficacy of levofloxacin and ceftazidime in acute exacerbation of bronchiectasis.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Bronchiectasis; Ceftazidime; Cephalospor | 1999 |
[Efficacy of single-dose therapy with levofloxacin for acute cystitis: comparison to three-day therapy].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Anti-Infective Agents, Urinary; Child | 2000 |
An open, non comparative study of ofloxacin i.v. on the treatment of acute symptomatic urinary tract infection.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacterial Infections; Dose-Response Relationship, Drug; Drug | 2000 |
Eradication of non-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or 10 days.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Double-Blind Method; Enteritis; Humans; Middle Ag | 2000 |
Efficacy of ofloxacin and other otic preparations for acute otitis media in patients with tympanostomy tubes.
Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Child; Child, P | 2001 |
Randomized, double-blind study comparing 5- and 7-day regimens of oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agen | 2001 |
Spectrum and susceptibility of pathogens causing acute uncomplicated lower UTI in females and its correlation to bacteriologic outcome after single dose therapy with fosfomycin trometamol versus ofloxacin/co-trimoxazole.
Topics: Acute Disease; Adolescent; Adult; Aged; Drug Administration Schedule; Female; Fosfomycin; Humans; Mi | 1992 |
Single-dose treatment of female acute uncomplicated cystitis.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Clinical Protocols | 1992 |
[Clinical efficacy of levofloxacin (LVFX) single-dose therapy in female acute uncomplicated cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Cystitis; Escherichia coli; Female; Humans; Levofloxacin; Mi | 1992 |
Once daily versus every two week multidose ofloxacin in patients with acute exacerbations of chronic respiratory disease.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchiectasis; Bronchitis; Chr | 1991 |
Single-dose and three-day regimens of ofloxacin versus trimethoprim-sulfamethoxazole for acute cystitis in women.
Topics: Acute Disease; Adult; Cystitis; Female; Humans; Ofloxacin; Perineum; Rectum; Trimethoprim, Sulfameth | 1991 |
A randomized trial of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis.
Topics: Acute Disease; Adult; Ambulatory Care; Cefoxitin; Chi-Square Distribution; Chlamydia Infections; Chl | 1991 |
Open randomized controlled parallel study of ofloxacin versus trimethoprim-sulfamethoxazole treatment of lower respiratory tract and urinary infections.
Topics: Acute Disease; Aged; Bronchitis; Bronchopneumonia; Chronic Disease; Cystitis; Escherichia coli; Fema | 1991 |
Ofloxacin versus trimethoprim-sulfamethoxazole for treatment of acute cystitis.
Topics: Acute Disease; Adult; Cystitis; Drug Resistance, Microbial; Feces; Female; Humans; Ofloxacin; Perine | 1989 |
A clinical comparative study of ofloxacin and pivampicillin in acute exacerbations of chronic bronchitis.
Topics: Acute Disease; Ampicillin; Bronchitis; Double-Blind Method; Female; Humans; Male; Ofloxacin; Pivampi | 1988 |
[Clinical evaluation of ofloxacin in the treatment of acute cystitis].
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Clinical Trials as Topic; Cystitis; Fe | 1987 |
Ofloxacin versus trimethoprim-sulphamethoxazole in acute cystitis.
Topics: Acute Disease; Anti-Infective Agents; Cystitis; Drug Combinations; Female; Humans; Infant, Newborn; | 1987 |
78 other studies available for ofloxacin and Acute Disease
| Article | Year |
|---|---|
Condensed bridgehead nitrogen heterocyclic system: synthesis and pharmacological activities of 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives of ibuprofen and biphenyl-4-yloxy acetic acid.
Topics: Acute Disease; Analgesics; Animals; Bacteria; Diphenylacetic Acids; Female; Fungi; Hepatocytes; Ibup | 2008 |
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
Topics: Acute Disease; Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Biological | 2014 |
Spontaneous bleb formation in a presumed pellucid marginal corneal degeneration with acute hydrops.
Topics: Acute Disease; Anti-Bacterial Agents; Aqueous Humor; Blister; Combined Modality Therapy; Corneal Dis | 2013 |
Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Catchment Area, Heal | 2014 |
Acute Bilateral Toxic Endotheliitis Following Alcohol Consumption.
Topics: Acute Disease; Adult; Alcohol Drinking; Anti-Bacterial Agents; Cataract; Cataract Extraction; Cornea | 2018 |
Antibiotic prophylaxis in severe acute pancreatitis: do we need more meta-analytic studies?
Topics: Acute Disease; Antibiotic Prophylaxis; Carbapenems; Cefuroxime; Ciprofloxacin; Humans; Meta-Analysis | 2009 |
[Acute pancreatitis associated with levofloxacin].
Topics: Acute Disease; Anti-Bacterial Agents; Female; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pancreat | 2009 |
Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Ind | 2009 |
Acinetobacter lwoffii: bacteremia associated with acute gastroenteritis.
Topics: Acinetobacter; Acinetobacter Infections; Acute Disease; Anti-Bacterial Agents; Bacteremia; Community | 2009 |
Acute hepatitis associated with the use of levofloxacin.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Biopsy, Needle; Chemical and Drug Induced Liver Injury; | 2010 |
Ofloxacin: new applications for the prevention of urinary tract infections in renal graft recipients.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Drug Resistance, Bacterial; Dru | 2011 |
[Acute cholestatic hepatitis associated with levofloxacin].
Topics: Acute Disease; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepa | 2011 |
[A case of acute phlegmonous gastritis causing gastroparesis and cured with medical treatment alone].
Topics: Acinetobacter; Acute Disease; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftri | 2011 |
Concurrent postpartum uterine and abdominal wall dehiscence and Streptococcus anginosus infection.
Topics: Abdominal Wall; Acute Disease; Adolescent; Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Cesarean | 2011 |
[Acute Mycoplasma pneumonia pancreatitis].
Topics: Abdominal Pain; Acute Disease; Anti-Bacterial Agents; Antibodies, Bacterial; China; DNA, Bacterial; | 2011 |
Rapidly fatal community-acquired pneumonia due to Klebsiella pneumoniae complicated with acute myocarditis and accelerated idioventricular rhythm.
Topics: Accelerated Idioventricular Rhythm; Acidosis, Lactic; Acute Disease; Community-Acquired Infections; | 2012 |
[The improvement of complex treatment of odontogenous periostitis in elderly patients].
Topics: Acute Disease; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacteria | 2012 |
[Update on the role of levofloxacin in the management of acute community-acquired pneumonia].
Topics: Acute Disease; Anti-Infective Agents; Bacteremia; Community-Acquired Infections; Humans; Levofloxaci | 2002 |
[Update on the use of levofloxacin in the management of acute exacerbations of chronic bronchitis with risk factors].
Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Chron | 2002 |
Anthrax attacks and practice patterns: a learning opportunity for health care systems.
Topics: Acute Disease; Alabama; Ambulatory Care Facilities; Anthrax; Antibiotic Prophylaxis; Bioterrorism; C | 2002 |
[Therapeutic and diagnostic policy in acute sinusitis].
Topics: Acute Disease; Adult; Algorithms; Anti-Bacterial Agents; Bacteria; Child; Diagnosis, Differential; H | 2002 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ceph | 2001 |
Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient.
Topics: Acute Disease; Aged; Anti-Infective Agents; Cellulitis; Chemical and Drug Induced Liver Injury; Huma | 2003 |
Acute urethritis caused by Neisseria meningitidis.
Topics: Acute Disease; Anti-Infective Agents, Urinary; Humans; Levofloxacin; Male; Meningococcal Infections; | 2003 |
A 65-year-old woman with acute cough illness and an important engagement.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antitussive Agents; Antiviral Age | 2003 |
[Susceptibility of major pathogens of acute pharyngitis and tonsillitis to levofloxacin and other oral antimicrobial drugs].
Topics: Acute Disease; Ampicillin; Anti-Infective Agents; Azithromycin; Cefdinir; Cefpodoxime; Ceftizoxime; | 2003 |
Acute hepatitis associated with levofloxacin in a patient with renal insufficiency.
Topics: Acute Disease; Alkaline Phosphatase; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; | 2003 |
[Use of the antibacterial agent levofloxacin for acute upper respiratory tract infection accompanied by fever (> or = 38 degrees C)].
Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Bacterial Agents; Body Temperature; Drug Administration | 2003 |
Management of acute epididymitis: are European guidelines being followed?
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Chlamydia Infections; C | 2004 |
[Efficacy of levofloxacin in the treatment of acute exacerbation of chronic bronchitis in patients with risk factors].
Topics: Acute Disease; Anti-Bacterial Agents; Bronchitis; Chronic Disease; Clinical Trials as Topic; Humans; | 2004 |
Effects of selected antibiotics on pancreatitis induced liver and pulmonary injury.
Topics: Acute Disease; Alanine Transaminase; Amylases; Animals; Anti-Bacterial Agents; Aspartate Aminotransf | 2005 |
Acute localized exanthematous pustulosis secondary to levofloxacin.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Drug Eruptions; Exanthema; Humans; Levofloxacin; Male; O | 2005 |
Kocuria kristinae infection associated with acute cholecystitis.
Topics: Acute Disease; Anti-Bacterial Agents; Cholecystitis; Gram-Positive Bacterial Infections; Humans; Lev | 2005 |
Editorial commentary: dilemma in trial design: do current study designs adequately evaluate effectiveness antibiotic in ABRS?
Topics: Acute Disease; Azithromycin; Bacterial Infections; Chemistry, Pharmaceutical; Dose-Response Relation | 2005 |
Ascites in the puerperium: a missed diagnosis of acute postpartum pancreatitis.
Topics: Abdominal Pain; Acute Disease; Adult; Anti-Infective Agents; Ascites; Clarithromycin; Diagnosis, Dif | 2005 |
The safety of levofloxacin in elderly patients on warfarin.
Topics: Acute Disease; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; Case-Con | 2005 |
Moxifloxacin versus levofloxacin for treatment of acute rhinosinusitis: a retrospective database analysis of treatment duration, outcomes, and charges.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Aza Compounds; Database Management Systems; Female; Flu | 2006 |
Value of short-course antimicrobial therapy in acute bacterial rhinosinusitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Dose-Response Relat | 2005 |
[Acute respiratory failure and septic shock induced by Mycobacterium bovis. A rare side effect of intravesical BCG therapy].
Topics: Acute Disease; Administration, Intravesical; Aged; Anti-Bacterial Agents; BCG Vaccine; Ceftriaxone; | 2006 |
Treatment of acute post-surgical infection of joint arthroplasty.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacemen | 2006 |
Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates.
Topics: Acute Disease; Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Ciprofloxac | 2007 |
Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cricetinae; Disease Models, Animal; Do | 2007 |
[Drug-resistant bacteria isolated from pharyngeal swab cultures and urine in acutely or chronically febrile elderly nursing home inmates].
Topics: Acute Disease; Aged; Chronic Disease; Drug Resistance, Bacterial; Escherichia coli; Fever; Fluoroqui | 2007 |
[In vitro activity of levofloxacin against Escherichia coli strains in acute pyelonephritis, in France in 2005].
Topics: Acute Disease; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; France; Humans; | 2007 |
Characterization and dynamics of middle ear fluid and nasopharyngeal isolates of Streptococcus pneumoniae from 12 children treated with levofloxacin.
Topics: Acute Disease; Anti-Bacterial Agents; Child, Preschool; Drug Resistance, Bacterial; Electrophoresis, | 2008 |
Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Dela | 2007 |
Fluoroquinolone-resistant group B streptococci in acute exacerbation of chronic bronchitis.
Topics: Acute Disease; Aged, 80 and over; Anti-Bacterial Agents; Bronchitis; Chronic Disease; DNA Gyrase; Dr | 2008 |
[The investigation of prostatic fluid and tissue levels of DL-8280 and clinical study of DL-8280 in acute prostatitis].
Topics: Acute Disease; Adult; Anti-Infective Agents; Humans; Male; Middle Aged; Ofloxacin; Oxazines; Prostat | 1984 |
[Acute suppurative parotitis caused by Pseudomonas aeruginosa].
Topics: Acute Disease; Aged; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Ofloxacin; | 1994 |
Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Infective Agents; Bacteremia; Drug Resistance, Micr | 1994 |
In vivo efficacies of levofloxacin and ciprofloxacin in acute murine hematogenous pyelonephritis induced by methicillin-susceptible and-resistant Staphylococcus aureus strains.
Topics: Acute Disease; Animals; Anti-Infective Agents; Ciprofloxacin; Colony Count, Microbial; Female; Kidne | 1996 |
Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Dru | 1997 |
Prophylaxis of acute osteomyelitis with absorbable ofloxacin-impregnated beads.
Topics: Absorption; Acute Disease; Animals; Anti-Infective Agents; Bone and Bones; Female; Microspheres; Ofl | 1998 |
Can quinolones cause hemorrhagic colitis of late onset? Report of three cases.
Topics: Acute Disease; Adult; Anti-Infective Agents; Bacterial Infections; Colitis; Colonoscopy; Enoxacin; F | 1999 |
Acute rhabdomyolysis during treatment with ofloxacin-a case report.
Topics: Acute Disease; Anti-Infective Agents; Escherichia coli Infections; Female; Humans; Middle Aged; Oflo | 1999 |
A 14-year-old boy with kidney allograft failure in the first month after transplantation.
Topics: Acute Disease; Adolescent; Anti-Infective Agents, Urinary; Biopsy; Creatinine; Diagnosis, Differenti | 2000 |
[Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
Topics: Acute Disease; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacterial Infections; Bronchit | 2000 |
Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure.
Topics: Acute Disease; Acute Kidney Injury; Anti-Infective Agents; Anti-Inflammatory Agents; Biopsy; Bronchi | 2001 |
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Female; Humans; Levofloxacin; Male; Meningitis, E | 2001 |
Possible levofloxacin-induced acute hepatocellular injury in a patient with chronic obstructive lung disease.
Topics: Acute Disease; Aged; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Female; Humans; | 2001 |
[A case of acute focal bacterial nephritis].
Topics: Acute Disease; Adult; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Focal In | 2001 |
[Acute pancreatitis after treatment by levofloxacin and methylprednisolone].
Topics: Acute Disease; Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Female; Humans; Levofloxacin; | 2001 |
[Levofloxacin and acute confusional syndrome].
Topics: Acute Disease; Adult; Anti-Infective Agents; Confusion; Humans; Levofloxacin; Male; Ofloxacin | 2002 |
Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin.
Topics: Acute Disease; Adult; Chlamydia Infections; Emergency Medical Services; Female; Follow-Up Studies; G | 1992 |
[Acute nongonococcal epididymitis--pharmacological and therapeutic aspects of levofloxacin].
Topics: Acute Disease; Administration, Oral; Adult; Chlamydia trachomatis; Epididymis; Epididymitis; Humans; | 1992 |
Comparative activity of fluorinated quinolones in acute and subacute Streptococcus pneumoniae pneumonia models: efficacy of temafloxacin.
Topics: Acute Disease; Animals; Anti-Infective Agents; Disease Models, Animal; Female; Fluoroquinolones; Mic | 1991 |
Multiple-dose-kinetics of ofloxacin after intraperitoneal application in CAPD patients.
Topics: Acute Disease; Aged; Dialysis Solutions; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; | 1991 |
Ofloxacin-induced acute severe hepatitis.
Topics: Acute Disease; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Female; Humans; Oflo | 1991 |
[Initial therapy of acute unilateral epididymitis using ofloxacin. I. Clinical and microbiological findings].
Topics: Acute Disease; Adult; Bacterial Infections; Bacteriuria; Chlamydia trachomatis; Epididymitis; Follow | 1990 |
[Initial therapy of acute unilateral epididymitis using ofloxacin. II. Andrological findings].
Topics: Acute Disease; Adult; Epididymitis; Follicle Stimulating Hormone; Humans; Male; Middle Aged; Ofloxac | 1990 |
[The combination of penicillin G and ofloxacin: a response to the empirical treatment of community acquired pneumonia].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Therap | 1990 |
[Single day treatment in acute cystitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Cystitis; | 1988 |
[Clinical experience with ofloxacin in the treatment of chronic respiratory tract disease aggravated by acute infection].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Female; Haemophilus influenzae; Humans; Male; Middle | 1988 |
[The role of ofloxacin (Tarivid) therapy in respiratory and urinary tract infections].
Topics: Acute Disease; Chronic Disease; Escherichia coli; Humans; Klebsiella; Ofloxacin; Proteus; Pseudomona | 1987 |
[Ofloxacin in the conservative therapy of acute and chronic otitis media--a preliminary clinical report of experiences].
Topics: Acute Disease; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chronic Disease; Humans; Oflox | 1986 |
Ofloxacin in oral chemotherapy of acute and chronic otitis media.
Topics: Acute Disease; Anti-Bacterial Agents; Chronic Disease; Ear, Middle; Humans; Ofloxacin; Otitis Media; | 1986 |
[Clinical study of ofloxacin (OFLX) on urinary tract infections].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Bacteria; | 1987 |
Acute nongonococcal epididymitis. Aetiological and therapeutic aspects.
Topics: Acute Disease; Adolescent; Adult; Aging; Anti-Infective Agents; Epididymitis; Humans; Male; Middle A | 1987 |